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Summary 
 
Metalloproteins are involved in fundamental biological processes and utilize a relatively 
small    number of metal-based prosthetic groups to serve numerous and diverse chemical 
functions.1,2 
The hemeproteins family represents a fascinating example in this respect: a single 
prosthetic group, the heme, promotes a variety of functions, such as dioxygen storage and 
transport, electron transfer, hydroxylation and oxidation of organic substrates, and 
hydrogen peroxide disproportion. One of most interesting aspect is how the local protein 
environment surrounding the heme more finely regulates the heme-protein properties, such 
as the iron redox potential.   
With the aim of understanding the effects of the composition and conformation of the 
peptide chain in the modulation of the heme redox potential, it has been undertaken the 
development of porphyrin-peptide molecules, called mimochromes. 
They are pseudo-C2 symmetric systems, composed of two helical peptides covalently 
linked to the deuteroporphyrin. The use of C2 symmetry is particularly advantageous, 
because it simplifies the design, synthesis and characterization. However, it leaves the 
problem of possible diastereomeric forms. In the cobalt complex of the first derivative, 
mimochrome I, Λ and ∆ isomers were indeed experimentally observed. All the insights 
derived from the Co(III) mimochrome I structure were used to obtain a re-designed 
molecule, mimochrome IV. The spectroscopic characterization of the iron and cobalt 
derivatives suggested the presence of the Λ isomer as unique species. The NMR solution 
structure of the diamagnetic Co(III)-mimochrome IV confirmed the ability of the molecule 
to adopt a unique topology, and revealed the peptide chains to be in helical conformation, 
as designed. The stereochemically stable structure of mimochrome IV provides an 
attractive model for modulating the redox potential of the heme, by simple changing the 
peptide chain composition around the heme. To this goal two new analogues, which are 
characterized by different charges,  have been development mimochrome IV 8Lys and 
                                                 
1
 Lippard, S. J.; Berg, J. M. Principles of Bioinorganic Chemistry; University Science Books: Mill Valley   
2
 Holm, R. H.; Kennepohl, P.; Solomon, E. I. Chem. Rev. 1996, 96, 2239. 
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mimochrome IV 8Glu, which contain into their sequences eight Lys residues and eight Glu 
residues, respectively (see figure 1). 
 
 
 
  
                                         R=R1; Peptide mimchromes 
 
                                     
 
 
 
 
 
Figure 1: Structure of  Fe mimochromes  
 
The effect of such different charges on the peptide conformation and on the coordination 
strength has been investigated in detail, by UV-vis and CD spectroscopies while the effect 
of the charge distributions on redox properties of metal centre, was determined by 
experiments of square wave voltammetry.  
 
 
 
 
 
 
 
 
 
 
Mimochrome Peptide Sequence 
   8Glu Ac-Glu-Glu-Glu-Leu-His-Glu-Glu-Lys-Arg-NH2 
8Lys Ac-Glu-Lys-Lys-Leu-His-Lys-Lys-Lys-Arg-NH2 
IV Ac-Glu-Ser-Gln-Leu-His-Ser-Asn-Lys-Arg-NH2 
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Chapter 1: Hemeprotein, structures and functions 
 
Metalloproteins are involved in fundamental biological processes and utilize a relatively 
small number of metal-based prosthetic groups to serve numerous and diverse chemical 
functions1,2. The hemeprotein family represents a fascinating example in this respect: a 
single prosthetic group, the heme, promotes a variety of functions, such as dioxygen 
storage and transport, electron transfer, hydroxylation and oxidation of organic substrates, 
and hydrogen peroxide disproportion3. How different proteins are able to fine-tune the 
environment of the heme cofactor, thus producing such different chemistries, is becoming 
increasingly clear through the study of natural and artificial model systems. 
High-resolution X-ray crystallographic data as well NMR analysis available for an 
increasing number of heme-proteins, have deeply contributed to understanding their 
reactivity and structural and electronic properties at the molecular level4-16. It is now well 
ascertained that the protein matrix, which surrounds the heme active site, controls the 
intrinsic reactivity of the prosthetic group, selecting one reaction as the only or 
predominant one.  
 
 
 
 
 
 
 
 
                                         
                                    Myoglobin                                               Cytochrome c with heme c 
                                                
                                                            Figure 1.1:two natural heme proteins  
 
However the inherent complexity of natural heme proteins continues to obscure the full 
description of the factors governing the heme properties. 
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Therefore, a large number of artificial model systems are being developed in an attempt to 
(i) provide further insights for structure-activity relationships, (ii) understand the minimal 
requirements for function, (iii) reproduce the properties of the parent natural proteins in 
smaller molecules, and (iv) most importantly construct new, tailor-made molecules useful 
for biomedical, pharmaceutical, biological, and environmental applications. 
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1.1 Heme structure 
 
1.1.1  Properties of the porphyrin macrocycle 
 
The basic structure of natural heme protein is a tetrapyrrole macrocycle called porphyrin.         
The porphyrin (shown in figure 1.2) consists of four pyrrole-like five-membered units, A, 
B, C and D, which are linked by four methine bridges, 5, 10, 15, 20 (meso positions). The 
porphyrin macrocycle is an aromatic system containing 22 pi electrons, but only 18 of them 
are involved in a delocalization pathway. Porphyrin obeys Huckel's rule of aromaticity     
(4n + 2 pi electrons, n = 4) and is shown by X-ray crystallography to be planar. The 
aromatic character of porphyrins can also be seen by NMR spectroscopy. Due to the 
anisotropic effect from the porphyrin ring current, the NMR signals for the deshielded meso 
protons appear at low field (8 to 10 ppm), whereas the signals for the shielded protons (on 
the inner nitrogen atoms) appear at very high field (-2 to -4 ppm).  
 
 
 
 
 
 
 
 
Figure1.2: Basic structure of the porphyrin macrocycle: numbering, functionalization sites and planarity. 
 
The  identity of porphyrin in natural heme proteins is distinguished by its peripheral          
β-pyrrolic substituents, as shown in Figure 1.3. The most common heme tetrapyrrole 
macrocycle is heme b or iron(II) protoporphyrin IX17. The term “heme” specifically refers 
to the ferrous complex of protoporphyrin IX, with the ferric-hydroxy and ferric-chloride 
complexes referred to as hematin and hemin, respectively. Heme b, also called protoheme, 
has methyl groups  at positions 3, 8, 13, and 17, vinyl groups at positions 7 and 12, and 
propionates at positions 2 and 18 on the macrocycle. 
 
β 
β 
meso 
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Figure1.3: Chemical structures of commonly occurring natural hemes a, b, c, and d. 
 
 
All the porphyrins are synthesized in vivo as the free base forms before incorporation of the 
iron(II) by the enzyme ferrocheletase18, 19. Additionally, heme b serves as the structure from 
which hemes a and c are biosynthetically derived. Heme c is structurally similar to heme b 
except that thioether bonds to cysteine residues replace one or both of the vinyl groups and 
covalently link the heme macrocycle directly to the protein scaffold20. The covalent 
attachment of heme to the protein is effected by the enzyme heme lyase,21 but  in vitro 
chemical synthesis has also been used to form the thioether bonds in b-type cytochrome 
and c-type cytochrome scaffolds22-24. Instead Heme a is biosynthesized from heme b by 
conversion of the vinyl group at position 2 into a hydroxyethylfarnesyl side chain, yielding 
heme o, followed by subsequent oxidation of the methyl at position 8 to a formyl group23. 
These alterations render heme a both more hydrophobic and more electron-withdrawing as 
an equatorial ligand to iron than heme b. Other less common heme architectures include 
heme d25, heme P-46026, siroheme27, and chlorocruoroheme28. 
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1.1.2 Coordination properties 
 
It is now well ascertained that the protein matrix, which surrounds the heme active site, 
controls the intrinsic reactivity of the prosthetic group, selecting one reaction as the only or 
predominant one. The protein composition and structural organization of the peptide chain 
dictate the properties of the primary (metal coordination geometry, number, type, and donor 
properties of the axial ligands) and secondary (local dielectric constant, hydrophobicity, 
and hydrogenbonding interactions near the active site coordination sphere) coordination 
shells. Further, the protein directs long-range interactions29. These factors all contribute to 
the functional specificity of the heme.  
It has been well recognized that in the primary coordination sphere, therefore the axial 
ligands to the iron in eme proteins, play important roles in modulation of structure and 
function of heme proteins, such as redox potentials, electronic structure, spin states, 
electron-transfer rates, and catalytic properties30-37. 
Several amino acids are known to serve as axial or proximal ligands to heme proteins30-32. 
In cytochromes (cyt), histidine, methionine, lysine, and cysteine are common axial ligands 
that coordinate the heme. Bis-His and His-Met coordination, found in cyt b5 and cyt c, 
respectively, are by far the most common ligation states of the cytochromes (Figure 1.4a). 
Other ligation states, such as bis-Met and His-Lys, have also been found. Interesting 
ligation from the terminal α-amino group of a peptide bond has been observed in cyt f 
(Figure 1.4a)38. Heme-based sensors and enzymes are mostly five coordinate with an open 
site for binding small molecules such as O2 and CO. In those proteins, histidine is by far the 
most common axial ligand, with cysteine and tyrosine found in a few classes of heme 
enzymes such as cyt P450, chloroperoxidase (CPO), and catalase (Figure 1.4b). Recently, a 
new axial ligand, the N-terminal nitrogen of proline, was discovered in the CO sensing 
heme protein called CooA (Figure 1.4b)39.  
While the axial ligands to heme iron establish the basic coordination chemistry, the 
interaction of amino acids beyond the primary coordination sphere is critical to modulating 
the chemical properties of the heme, allowing it to perform a variety of biochemical 
functions. 
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Figure 1.4a: Cytochromes with different axial ligand coordination 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
Figure 1.4b: Heme proteins with one open coordination site 
 
The local protein environment surrounding the heme more finely regulates the heme-
protein properties, such as the iron redox potential40-45. For instance, a large number of 
positively charged residues around the heme in hemoglobin and myoglobin may favor a 
low oxidation state for the iron, making it ready to bind dioxygen. On the contrary, the 
progressive change in the polarity of the surrounding peptide environment, from a negative 
charge distribution in cytochromes b to a positive one in cytochromes c, determines a 
          8 
gradual increase in the Fe(III)/Fe(II) redox potential. The resulting stabilization of the 
matching Fe(II) and Fe(III) states enables cytochromes to mediate the electron transfer. 
While the control of the functional specificity by the primary coordination sphere is well 
understood, the contribution of medium- and long-range interactions is still not completely 
rationalized, and their molecular description remains to be determined. Therefore, a large 
number of artificial model systems are being developed in an attempt to  
 
• provide further insights for structure-activity relationships; 
• understand the minimal requirements for function;  
•  reproduce the properties of the parent natural proteins in smaller molecules; 
• construct new, tailor-made molecules useful for biomedical, pharmaceutical, 
biological, and environmental applications. 
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Chapter 2:  Design of new metalloporphyrin scaffold 
 
2.1     Covalent Peptide-Porphyrin Systems 
 
In order to better understand the role of the peptide chain composition and folding in the 
control of the physico-chemical properties of the heme-proteins, a great deal of attention 
was devoted to the design of low molecular weight peptide based heme proteins mimetics. 
These molecules have been developed using quite different strategies. They differ in 
molecular structures, ranging from simple meso-substituted tetra-arylmetalloporphyrins to 
more complex peptide-porphyrin conjugates46. The chemical structures of porphyrins 
usually employed in model systems are illustrated in Figure 2.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Chemical structures of porphyrin rings: (A) protoporphyrin IX; (B) deuteroporphyrin IX;              
(C) mesoporphyrin IX; (D) mesoporphyrin II; (E) coproporphyrin; (F) meso-tetraphenylporphyrin. 
Commonly, the 5, 10, 15, and 20 positions have been also referred to as meso-positions. 
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A common feature in the compounds so far developed is the assembly, around the 
porphyrin ring, of several different chemical components, which are intended to fulfill the 
features of the protein matrix and make the heme ready to accomplish specific functions. 
As an example, to obtain oxygen carrier models, two main requirements are needed: (1) 
stabilization of a five-coordinate heme complex having an imidazole proximal ligand and 
(2) prevention from further oxidation of the iron-dioxygen complex47-50.  
In the natural systems these mandatory conditions for efficient reversible oxygen binding 
are accomplished by the presence of the steric bulkiness of the protein moiety, which 
blocks the formation of a µ-oxo bridge between two heme complexes and brings the axial 
ligand in the correct coordination position. 
On the other hand, a chemical model system for the dioxygen activation, resembling the 
cytochrome-P450 catalytic cycle and efficiency, should embody the following features.   
(1) An axial thiolate ligand should be present, as it fundamentally contributes to the 
heterolytic cleavage of O-O bond and modulates the intrinsic reactivity of the high valent 
iron-oxo species. (2) A steric protection of the porphyrin ring is required to prevent the 
rapid degradation of the catalyst by the oxidizing species produced during the reaction. (3) 
Further, to control the chemio-, regio-, and stereoselectivity in oxygenation reactions, a 
chiral environment, able to selectively recognize a defined substrate, should be constructed 
around the heme group51-54. 
The first studies on low molecular weight heme-protein models was based on the 
construction around the heme of bulky moieties by covalently linking aromatic or aliphatic 
substituents to the porphyrin ring 47-54.Unfortunately the low functionality of these model 
systems have not  permitted their use in pratical applications. Nevertheless these molecules 
have gained considerable success at a molecular level, because they have better helped to 
better understand the properties of the natural heme-proteins. (Figure2.2) 
In more recent years, the field of heme-protein mimetics broadens to include more 
elaborate peptide based models. Peptide-based models are having an enormous impact on 
our understanding of the factors governing the heme properties, as they seem to be better 
candidates to mimic both the structural characteristics and reactivity of the natural systems. 
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Figure 2.2: Schematic representations of substituted porphyrins as cytochrome P450 models: 
                   (a) first-, second-, and third-generation meso-tetraaryl substituted porphyrins 51,52, 
                   (b) anionic porphyrin55, and (c) cationic porphyrin 56.  
 
Peptide architecture around the heme can serve for substrate recognition and to reproduce 
the efficient chemio-, regio-, and stereoselectivity of natural heme-proteins. Peptide models 
stand at the crossroads of small molecule models and large proteins. Their structures are 
simple and hence more easily understood than their natural counterparts. They 
simultaneously have sufficient size and chemical diversity to allow the construction of 
functional binding and catalytic         sites 57-62. 
The development of peptide-based models takes advantage of recent progress in both the 
design and synthesis of peptides and proteins. It is now possible to construct rigid scaffolds 
able to accommodate substantial changes in their sequence without loosing their three-
dimensional structure because the principles governing folding and stability of peptides and 
proteins are better understood and advanced tools for their design are available 63-72. Hence, 
it is possible to build recognition and catalytic sites in a scaffold and to systematically vary 
the amino acid composition, thus allowing one to (1) optimize the structural and functional 
properties of the initial target, in terms of stability, catalytic activity and selectivity, (2) test 
how small changes in the sequence affect the properties of the heme and whether they are 
able to switch the heme function from one to another, and (3) investigate not only the effect 
of variation in the first coordination sphere but also the influence on the activity of 
medium- and long-range interactions. 
Peptide models offer the additional advantage of solubilizing the high hydrophobic heme in 
aqueous solution by simply accommodating the heme group in a hydrophobic pocket of an 
amphiphilic structure. 
          12 
2.2 Spectral Properties of Metal-Porphyrins and Heme-Proteins 
 
UV-vis spectroscopy has been widely applied for the characterization of peptide-based 
heme-protein models because it is one of the most powerful techniques for the analysis of 
the heme properties. Useful information on artificial porphyrin-containing systems can be 
obtained by comparing their spectral properties with those of natural heme-proteins and 
viceversa. This section will provide a brief survey of the main spectral features of 
metalloporphyrins and heme-proteins, which could be helpful to nonspecialists in 
understanding the subsequent sections. For a more detailed description of porphyrin and 
metalloporphyrin spectra together with the theoretical aspects of the spectral transitions, the 
readers can refer to many excellent reviews on the arguments 73-76. 
The porphyrins and their various metal complexes show very distinct spectra, and UV-vis 
spectroscopy can be conveniently applied to ascertain the insertion of the metal into the 
porphyrin ring, the oxidation and spin state of the metal, and the nature of the axial ligands. 
The highly conjugated pi-electron system of the porphyrin ring is responsible for its intense 
color. Two pi → pi* electronic transitions are responsible for the absorption bands, typically 
found in the porphyrin spectra73-76. An intense band (molar extinction coefficient  ≈ 105 M-1 
cm-1) is detected around 400 nm, and it is referred to as the B band, Soret band, or γ band; 
much weaker bands (molar extinction coefficient ≈ 104 M-1 cm-1) are observed in the 500-
600 nm visible region. These weaker bands are referred to as Q bands or β-α bands. The α 
band corresponds to the lowest porphyrin pi → pi* singlet transition Qo and the β band to the 
vibronic envelope Qv73,74. The visible bands are very sensitive to the metal inserted into the 
porphyrin ring and to peripheral substituent groups. The Qo and Qv transitions are polarized 
in the x, y plane of the porphyrin; for a metal porphyrin with D4h symmetry, the dipole 
transitions in the x and y directions are equivalent and both the Qo and Qv transitions are 
doubly degenerate. Thus, the spectrum of a metal porphyrin usually shows two bands in the 
visible region. In free base porphyrins, two protons are linked to two opposite inner 
nitrogens (see Figure 1). In this case, the porphyrin plane no longer possess the 4-fold 
symmetry and β and α bands splits. In fact, the degenerate Qo transition is replaced by 
transitions polarized along each of the nonequivalent x and y axes, Qox and Qoy.              
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Each transition has its vibronic envelope (Qvx and Qvy), and, as a consequence, four distinct 
bands characterize the spectrum of free base porphyrins in the visible region73-76. 
The positions of the Soret, β, and α bands depend on the metal electron configuration, and 
the energy of the transitions varies as a consequence of the coupling between the metal and 
the porphyrin orbitals. The absorption spectra of metalloporphyrins are thus classified into 
three types, normal, hypso, and hyper 76. 
Normal-type spectra are observed for a majority of metalloporphyrins with closed-shell 
metal ions, where the relevant porphyrin pi orbitals do not significantly interact with the 
metal orbitals. The Soret, α, and β bands are often found around 400, 570, and 530 nm, 
respectively.  
Hypso-type spectra follow the normal absorption pattern, but all bands are blue-shifted, due 
to filled metal d orbitals to porphyrin pi* back-donation. Metal ions that cause hypso-type 
spectra are limited to those of d6-d9 electron configurations.  
Finally, hyper-type spectra show charge-transfer bands in addition to a significant red-shift 
of the porphyrin pi-pi* bands. They are difficult to analyze because the number of extra 
bands varies from one metal ion to another and the positions of all bands are far more 
dependent on the axial ligands than in the other types 76. Metal ions with d1-d5 electron 
configurations show these hyper-type spectra. Most of them can be easily found in lower 
oxidation states within the porphyrin, causing normal- or hypso-type spectra. Mn(III)- and 
Fe(III)-porphyrins are the best known examples in this respect. 
The UV-vis spectra of heme-proteins show absorption patterns quite similar to those 
observed in simple metalloporphyrins. They are very sensitive to the oxidation and spin 
state of the iron, which are modulated by the protein environment. In addition to the Soret, 
β, and α bands, four extra bands are found in the lower energy of the visible region, and 
they are usually referred to as IV, III, II, and I. The typical UV-Vis absorption data for 
several hemoproteins are reported in Table 2.174,75,77-80. 
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Soret β α 
Protein 
axial 
ligands 
spin 
state 
λmax 
(nm) 
ε × 10-3        
(M-1cm-1) 
λmax    
(nm) 
ε × 10-3         
(M-1 cm-1) 
λmax 
(nm) 
ε × 10-3                       
(M-1 cm-1) 
Sperm whale Mba 
MbO2  His/O2 LS 418 128 543 14.6 581 13.6 
MbCO  His/CO LS 423 187 542 14.0 579 12.2 
Mb  His/H2O HS 434 115 556 11.8 588 sg 
Horse Hbb  
HbO2  His/O2 LS 415 129 540 14.1 576 14.9 
HbCO  His/CO LS 419 192 539 13.9 569 13.9 
Hbh  His/H2O HS 430 130 555 12.9 590 sg 
cyanomet-Hb  His/CN LS 422 114 542 10.9 575 sg 
aquomet-Hbi  His/H2O HS 405 169 500 9.0 540 sg 
Cytochromes 
E. coli b562 red
c  His/Met LS 427 180 531 17.6 562 32.1 
E. coli b562 ox
c  His/Met LS 419 117 531 11.3 564 9.30 
chloroplast b559 
redd  
His/His LS 427 - 530 - 559 - 
chloroplast b559 
oxd  
His/His LS 413 - 534 - 562 - 
michrosomes b5 
reda  
His/His LS 423 - 527 - 555 - 
michrosomes b5 
oxe  
His/His LS 413 117 530 11.0 560 9.16 
P450-CAMf  Cys/H2O LS 417 115 536 10.6 569 11.1 
Table 2.1: a Data from ref 74.b Data from ref 75.c Data from ref 77.d Data from ref 78.e Data from ref 79.f 
Data from ref 80g s indicates that the band produces a shoulder.h The III and I bands are detected at 758 nm    
(  = 375 M-1 cm-1) and 910 nm (  = 195 M-1 cm-1), respectively, and are diagnostic for the HS state.i The IV 
and III bands are detected at 580 nm (  = 3400 M-1 cm-1) and 633 nm (  = 3900 M-1 cm-1), respectively, and 
are diagnostic for the HS state. 
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2.3 Microperoxidases 
 
Peptide-based hemoprotein models have been developed in order to reproduce better in 
model systems the physical-chemical properties of the natural systems. Microperoxidases 
(MP8 and MP11) have been widely employed as biomimetic models for heme-containing 
enzymes. 
The microperoxidases (MPs) are the heme-protein containing the consensus cyt c CXXCH 
sequence motif, as shown in Figure 2.3. They can be obtained by the cytochrome c 
proteolysis with digestive enzymes. The most important microperoxidase are 
Microperoxidase-11 (MP-11), isolated from pepsin digestion, and microperoxidase-8     
(MP-8), isolated from trypsin digestion, contain 11 and 8 amino acids, respectively. While 
the number of residues contained in microperoxidases depends on the proteolysis 
conditions, all contain the covalently linked c-type heme with a histidine axial ligand.  
 
 
 
 
 
 
 
                   
 
                    Figure 2.3: Schematic representation of the microperoxidase framework 
 
In the MP8, the porphyrin is covalently attached to the protein fragment through thioether 
linkages with Cys residues at positions 14 and 17; in the MP11, the peptide fragment 
corresponds to the 11–21 amino acid sequence of the protein. The His residue at position 
18 in both systems acts as axial ligand to the iron ion, leaving the sixth coordination site 
able to accommodate exogenous ligands or substrates. MP8  and MP11 have been tested in 
a wide number of catalytic reactions, such as peroxidase like and cytochrome P450-like 
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reactions. They are able to activate hydrogen peroxide to give high valence iron               
oxo species.  
The applications of these systems are limited low stability under the catalytic conditions: 
the porphyrin ring is rapidly degraded either by the direct action of H2O2 or by 
intermolecular reactions between the iron-oxo species and a non-activated molecule of the 
catalyst. However, their stability is higher than that of simple protoporphyrin systems, thus 
indicating that the presence of a small peptide chain can play an important protective role. 
Recently 81, the influence of peptide chain length and composition on the stability of the 
microperoxidases has been investigated. An increase in the size of, the attached polypeptide 
results in an increase in stability. The peptide chains can: (a) function as a scavenger for 
hydroxyl or superoxide radicals; (b) make a barrier for the formation of the inactive µ-oxo 
diiron dimer; (c) act as an alternative source of H-atoms, thus reducing the inactivation of 
the microperoxidase by H-atom abstraction from the meso position of the porphyrin ring. 
The analysis of the features of microperoxidases highlights the role of the peptide chains in 
modulating the reactivity of the heme ring. Furthermore, these molecules also serve as 
useful probes for the interpretation of some spectroscopic properties of synthetic heme-
peptide adducts 82. 
 
2.4 Peptide based-synthetic porphyrins 
 
 
The search for artificial catalytic systems able to reproduce the properties of natural 
hemeproteins is a key field in bioinorganic chemistry. The pioneering example of an 
artificial hemeprotein, based on a peptide-porphyrin conjugate system, was developed by 
Sasaki and Kaiser in an effort of using a porphyrin ring as a template to direct helical 
folding into the attached peptides 83-84. The resulting molecule, named “helichrome”, is 
characterized by four identical 15-residue peptide chains N-terminally linked to the four 
propionic groups of coproporphyrin I, shown in Figure 2.4. 
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                                             Figure 2.4: Schematic representation of the helichrome molecule 
 
 
Helichrome was designed to mimic the hydroxylase activity of cytochrome P450, whose 
structure is characterized by the presence of several α-helices surrounding the heme group 
and forming a hydrophobic recognition site. Therefore, the peptide sequence in helichrome 
was chosen such that it could stabilize an amphiphilic helix and create, in the folded state, a 
substrate binding hydrophobic pocket proximal to the porphyrin ring. 
Helichrome, by structural and functional characterization, showed quite remarkable 
features: 
• soluble in water above pH 3; 
• the peptide chain exhibits a high α-helical content as assessed by CD measurements; 
• is monomeric under the experimental conditions of the spectroscopic 
measurements; 
• The free energy of folding (-4.4 kcal mol-1) was determined to be comparable to that 
of native globular proteins. 
These properties have induced to use the helicrome in catalytic reactions. The aniline 
hydroxylase activity of the helichrome-iron(III) complex, from Kcat and Km values, showed 
to be similar to those of natural heme-proteins that possess this activity. 
Interestingly, the rigid hydrophobic pocket formed by the peptide chains plays  key role for 
helichrome activity because the iron(III) complex of the isolated coproporphyrin showed 
negligible catalytic activity under the same conditions.  
A quite similar approach was followed in the development of tetraphilins84. These 
molecules were designed with the aim of mimicking the activity of ion-channel proteins.  
          18 
To provide assemblies of defined aggregation state and drive amphiphilic peptides into four 
helix bundles, ion-channel-forming peptides were covalently attached to a 
tetraphenylporphyrin derivative (shown in Figure 2.5).  
 
 
 
 
 
 
 
 
 
                                                             Figure 2.5: Molecular model of tetraphyillin. 
 
Four copies of the 21-residue peptide (LSLBLSL)3 (B= α-aminoisobutyric acid) were 
covalently linked through the peptide N-terminus to meso-tetrakis (mcarboxyphenyl) 
porphyrin via m-carboxamido linkages. Meta substitution provides optimal interhelical 
spacing for ion transport. The tetraphilins properties in forming ion channels in planar 
diphytanoyl phosphatidylcoline bilayers indicated that the attachment of the peptide to the 
template stabilizes the conducting state of the peptide. Therefore, thetetraphenylporphyrin 
template exerts a major influence on the lifetime and voltage dependence of (LSLBLSL)3 
channels, possibly through changes in the overall hydrophobicity and geometric restrictions 
imposed on the peptide. 
In summary, heliochrome and tetraphilins are excellent examples of using a porphyrin 
template to direct the folding of peptides into a helical conformation. 
The use of porphyrin templates for inducing helical conformation in peptide sequences is as 
well reported in the papers of Benson85–87. With the aim of elucidating the forces which 
impart stabilization to protein structures, they developed peptide sandwiched mesoheme 
molecules85,87, in which a random coil–helix transition of two identical peptides, covalently 
attached to a iron III–mesoporphyrin IX moiety, occurs upon histidine to iron binding. 
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In a subsequent work86, the same effects have been investigated by using a                 
cystine-dimerized peptide containing two histidine residues. In the presence of              
cobalt ( III )–coproporphyrin I, the peptide self assembled around the macrocyclic ring.   
The authors concluded that these non-covalent model systems could be applied to probe the 
influence of peptide sequence and porphyrin structure on peptide conformational stability. 
A similar approach was followed by Mihara et al. in the design of heme-binding       
peptides88. A 14-residue peptide segment was designed to stabilize an amphiphilic α-helix 
structure. To construct a parallel 2α-helix structure the two segments were dimerized by the 
disulfide linkage of Cys16. 
Furthermore, a His residue was introduced at the position 6 of the sequence in order to 
coordinate a heme group. The CD and UV-Visible spectroscopic characterizations showed 
that the heme binding is controlled by the peptide conformation. Moreover, the formation 
of the heme–peptide complex enhances the N demethylase activity of the heme. 
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2.5 Peptide-Sandwiched Deuteroheme: Mimochromes 
 
Our laboratory has approached the challenge of constructing heme-protein models using a 
miniaturization process46. A miniaturized heme-protein is a peptide-based model which 
contains a minimum set of constituents necessary for  
• an accurate reconstruction of a well-defined structure and  
• a fine tuned reproduction of a defined function.  
This strategy leads to the development of a class of miniaturized heme-proteins, named 
mimochromes89-93. The schematic structures of mimochromes are reported in Figure 2.6.  
 
 
 
 1       
 
 
 
 
 
 
 
 
                     
                             Figure 2.6: Schematic representation of  mimochromes  
 
Mimochromes are peptide-porphyrin conjugates, with pseudo-C2 symmetry. They are made 
up of deuteroporphyrin, covalently linked to two peptides (nine or fourteen residues), via an 
amide bond between the porphyrin propionyl groups and the side chains of two Lys 
residues89-92. The peptide fragments, which face the porphyrin plane, are in α-helical 
conformation, a common feature of several natural heme-proteins. The α-helix is a well-
defined rigid scaffold, which can accommodate several amino acid substitutions without 
severe structural perturbations; therefore, numerous model compounds, based on helical 
Mimochrome Peptide sequence 
I   Ac-L-A-Q-L-H-A-N-K-L-NH2 
II Ac-D-L-S-D-L-H-S-K-K-L-K-I-T-L-NH2 
IV   Ac-E-S-Q-L-H-S-N-K-R-NH2 
R=R1  peptides sequence 
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peptides, have been developed94,95. The peptide sandwiched mesoheme85-87, the disulfide 
linked α-helices-mono-heme adducts96-98, the MOP derivatives99-101, and the heme-
maquettes102-105 are examples of either covalent or non-covalent artificial heme-peptide 
conjugates.  
The prototype mimochrome I was designed an the β-chain of human deoxyhemoglobin as 
template structure. The X-ray structure of deoxyhemoglobin106 showed that the proximal 
His89 residue is located in the central position of the Leu88-Leu96 protein fragment. This 
protein fragment adopts an helical conformation. It represents a rigid framework both for 
properly positioning His89 in the correct coordination site, and for completely covering one 
face of the heme. The helix axis is about parallel to the porphyrin plane; hydrophobic 
residues surround the axial coordinating residue and face the heme directly. 
All the information derived from the analysis of the natural systems served as starting 
points for engineering the mimochrome models. As a first step in this direction, we used the 
Leu88-Leu96 fragment as a scaffold for building an nine residue polypeptide sequence able 
to fold into an α-helical conformation89(see Figure 2.6). We appropriately changed the 
natural sequence by considering the factors that affect helix stability.  
 
 
 
 
 
 
 
                              
 
 
 Figure 2.6: Formula of mimochrome I: (3, 7, 12,17-tetramethyl-porphyrin-of Nε8-(Ac-Leu1-Ala2-Gln3-Leu4-
His5-Ala6-Asn7-Lys8-Leu9-NH2)-propionamide) 
 
Therefore we replaced Ser89 and Cys93 with alanine, which is known to have a high 
preference for the α-helical conformation. The resulting sequence contained five helix 
inducing residues, Leu1,4,9 and Ala2,6. Moreover, Glu90 and Asp94 were substituted with Gln 
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and Asn respectively, in order to obtain an uncharged compound. N- and C-terminal ends 
were acetylated and amidated, respectively, in order to avoid unfavorable end-charge to 
helix-dipole interactions. The peptide chain was then covalently linked to the porphyrin 
propionic group through the ε-amino function of Lys8. Molecular modeling showed that 
changing the side chain conformation of Lys95 as found on the β chain of deoxyemoglobin 
and the conformation of the closest propionyl carboxyl group, the lysine ε-amino group 
may approach the carboxyl group at bonding distance. Finally, an identical peptide chain 
was placed on the other side of the heme by applying a C2 symmetry operation (Figure 2.7) 
.  
 
 
 
 
 
 
 
                   
          
 
                    Figure 2.7: helix-heme-helix sandwich obtained by applying a C2 symmetry operation. 
 
The two covalent bridges between the peptide moiety and the porphyrin, together with the 
coordination of the two His residues, would make the peptide chains able to cover both 
heme faces. These factors would also serve as a strong local constraint to firmly keep the 
prosthetic group inside the hydrophobic cavity created by the two peptide chains. Finally, 
deuteroporphyrin was preferred to the most common protoporphyrin IX to avoid 
degradation of the sensitive vinyl substituents during the synthesis. 
The fully characterization of mimochrome I iron and cobalt complexes confirmed the 
design, even though some unexpected features were observed. The iron complex showed 
quite low solubility in water (in the µm range), in a wide range of experimental 
conditions90-92. Its detailed characterization was henceforth strongly limited. On the 
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opposite, the cobalt complex was soluble in water (up to mm concentration), but two 
equally abundant isomers were obtained (see Figure 2.8).  
Because of the flexibility of the linker between the peptide and the deuteroporphyrin ring, 
each peptide chain can be positioned either above or below the porphyrin plane, giving rise 
to Λ and ∆ diastereomers (see Figure 2.9)91. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure2.8: Schematic representation of the two possible orientations of the peptide chains around the metal   
center, which give rise to the two Λ and ∆ diastereomers. 
 
This finding was confirmed by the solution structural characterization89. In fact, the NMR 
structures of the two diamagnetic Co(III) isomers (Figure 2.9), which represent the first 
example of structure determination of a designed heme-protein models, allowed a definitive 
identification of the two isomers as the Λ and ∆ diastereomers and a straightforward 
correlation between their structure and spectral properties. As expected, the peptide chains 
adopt an almost regular α-helical conformation; the helices lie parallel to the porphyrin 
plane, and they are antiparallel to each other in the Λ isomer and about orthogonal in the ∆ 
isomer (see Figure 2.9). The analysis of the three-dimensional structure of the two cobalt 
isomers was important in understanding the properties of the Fe(II) and Fe(III) complexes, 
which could not be studied by NMR spectroscopy because of their poor solubility 
 
 
Λ ∆ 
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Figure 2.9: Average molecular structures of Co(III) mimochrome I ∆ and Λ isomers, as obtained from NMR        
experimental data and RMD calculations. 
 
The remarkably different solubility between the iron and cobalt complexes was tentatively 
attributed to the simultaneous presence of the two diastereomers, for the iron complex, in 
fast interconverting equilibrium. During this process both peptide chains might be 
displaced from the porphyrin plane. The porphyrin ring is thus exposed to the solvent, and 
aggregation by stacking of the porphyrin ring may occur. Confirmation for this hypothesis 
came from the CD spectral properties in the Soret region, which are an average of those 
corresponding to the two separate diastereomers (see Table 2.2). 
The unpredicted but experimentally observed Λ and ∆ isomers of Co(III)-mimochrome I 
clarify the concept of diastereomerism that may occur when polypeptides coordinate to 
metal ions. The use of local pseudo-C2 symmetry is particularly advantageous to construct 
symmetric molecules with minimized size, because it simplifies the design, reduces the size 
of the molecules to be synthesized, and may simplify their structural characterization107,108. 
However, great attention should be paid in the design to overcome the problem of 
diastereomer formation. 
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         Table 2.2: CD parameters for Mimochrome Derivativesa; (a), The intensities of the cotton effect are  
proportional to the number of  
 
 
The information derived from mimochrome I was fruitfully applied for improving the 
structure by design. Two strategies were used to reduce the peptide flexibility:  
 
• by elongating the peptide chain at the C-termini, with a four residue fragment, 
modeled in an extended conformation; 
• by amino acid substitutions that may provide intra-molecular, inter-chain 
interactions. 
 
The first strategy was successfully applied, as reported for mimochrome II, where the 
stabilization of the Λ isomer was achieved91. The second strategy led to the design of 
mimochrome IV, namely 3,7,12,17-tetramethylporphyrin-2,18-di-N8ε-(Ac-Glu1-Ser2-Gln3-
Leu4-His5-Ser6-Asn7-Lys8-Arg9-NH2)-propionamide. 
Mimochrome IV was designed by using the NMR structures of Co(III) mimochrome I ∆ 
and Λ isomers as templates90. Mimochrome I contains two leucine residues at both the N- 
and C-termini. These residues were selected in the initial design of mimochrome I, because 
UV region Soret region 
 
[ ]222 [ ] sign  
mimochrome I 
 
not detected  not detected 
Fe(III)-mimochrome I 
 
(-) ; (+)  S-shaped  
Co(III)-mimochrome I  
  
negative  
Co(III)-mimochrome I  
  
positive  
mimochrome II 
 
not detected  not detected  
Co(III)-mimochrome II 
  
negative  
mimochrome III 
  
negative  
Fe(III)-mimochrome III 
  
positive  
mimochrome IV 
 
not detected  not detected  
Fe(III)-mimochrome IV 
  
positive  
Co(III)-mimochrome IV 
  
positive 
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of their high propensity to be accommodated in α-helical conformation109. Further, we 
expected that hydrophobic interactions, between the leucine side chains and the porphyrin, 
would drive the helices to lay on the porphyrin. Nevertheless as mentioned previously , the 
sandwich was stable for the Co(III) derivative, and not for the FeIII 89,90. In order to provide 
an extra contribution to the stability of the sandwich, beside the metal coordination force, 
we modified the sequence of mimochrome I, by introducing intra-molecular, inter-helical 
interactions. 
The Cα atoms of Leu1 of one helix and of Leu9 of the other helix are about 12 Å apart in 
both isomers. At this distance, the carboxylate side chain of a Glu residue at position 1 of 
one peptide chain could ion pair with the guanidine group of an Arg residue at position 9 of 
the other peptide chain. Thus, Glu1 and Arg9, which replace Leu1 and Leu9, was inserted to 
stabilize one of the two possible diastereomers.  Further, the solvent exposed Ala2 and Ala6 
in mimochrome I were replaced by Ser residues in mimochrome IV in order to further 
increase the water solubility of the new molecule. 
The insertion of Glu and Arg residues at position 1 and 9 of the sequence, respectively, was 
successful in stabilizing the sandwich structure and in favoring the formation of Λ isomer 
(figure 2.10) over the other, both in the Fe(III) and Co(III) complexes. These results were 
confirmed by NMR data and RMD calculations110.  
 
 
 
 
 
 
Figure 2.10: Co(III)-mimochrome IV average structure as obtained from NMR data and RMD calculations  
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The UV-vis pH titration showed the iron bis-His coordination is strong enough to bring the 
His pKapp value around 3.8. The bis-His coordination is even stronger in Co(III) complex, 
and it  occurs at very acidic conditions (pH < 2). This finding is related to the high 
preference of cobalt for nitrogen donor ligands, and to the exchange- inertness of low-spin 
Co(III) complexes. These low pKa values of the axially coordinating His (with values very 
close to what observed in several myoglobins, hemoglobins and cytochromes in the 
oxidized and reduced forms) strongly support the designed sandwich structure111,112. 
CD spectra in the far UV region confirmed the peptide chain to be predominantly in an      
α-helical conformation in both the apo and metalated species, even at low TFE 
concentration. We also observed that the sign of the Cotton effect depends on the relative 
orientation of the peptide chains respect to the porphyrin plane. In the cobalt complexes of 
mimochrome I and II, the Λ configuration gives rise to a positive Cotton effect, whereas the 
∆ configuration gives rise to a negative effect; in the Fe(III) mimochrome I complex, the 
observed S-shaped Soret Cotton effect was attributed to the simultaneous presence of the 
two diastereomeric forms. Consequently, the presence of a positive Cotton effect in both 
Fe(III) and Co(III) mimochrome IV complexes indicates that both systems assume a               
Λ configuration. A single positive Cotton effect detected even in the iron complex 
confirmed the effectiveness of the inter-helical interactions in reinforcing the sandwich 
structure and in driving the peptide chains to fold into a unique topology around the heme. 
The definitive answer of the structural identity of the diastereomer stabilized in 
mimochrome IV was obtained by NMR structural characterization of the cobalt complex. 
The NMR analysis fully confirms the UV-vis and CD data, both regarding the helical 
conformation of the peptide chains, and the Λ configuration of the hexacoordinated CoIII 
ion. The RMD calculations, using the NMR experimental data as conformational restraints, 
indicated two helical peptide chains, oriented about perpendicularly.  
In summary, mimochrome IV is a simple, structurally defined heme protein model, which  
provide an excellent opportunity for exploring the subtle mechanisms that control the heme 
functions. The peptide structure of mimochrome IV is such that a partially open 
hydrophobic cage around the imidazole ring is present. Except for the position 20 of the 
deuteroporphyrin ring, all the other meso positions are covered by the polypeptide chains, 
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which, similarly to the natural systems, may protect the deuteroporphyrin ring from 
degradation during catalytic cycles. 
The amino acid composition of mimochrome IV can be modified in order to modulate the 
functionality in terms of redox potentials, trying to adapt the behavior to different 
applications. Substitution of serines, glutamines and asparagines, which point outward from 
the molecular core, with differently charged residues may alter the electrostatics, polarity 
and solvent accessibility of the heme site, and modulate its electronic, catalytic and binding 
properties. 
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Chapter 3: Design of new mimochromes 
 
On the  basis of results gotten by mimochromes development, we have drawn advantage 
from stereochemically stable structure of mimochrome IV for modulating the redox 
potential of the heme. Based on the mimochrome IV design, two news models were 
obtained: mimochrome IV 8Glu and mimochrome IV 8Lys (figure 3.1).  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Schematic structures of mimochrome IV,  mimochromeIV 8Glu , and  mimochrome IV 8Lys 
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Mimochrome IV 8Glu and mimochrome IV 8Lys  contain into their sequences differently  
charged residues: eight Glu residues and eight Lys residues, respectively, that replace Ser, 
Asn and Gln of the parent Mimochrome IV sequence. The impact of the charge on heme 
properties was studied in this work thesis 
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Chapter 4: Mimochromes synthesis 
 
4.1 Synthetic procedure 
 
Mimchrome IV, mimochrome IV 8 Glu and mimochrome IV 8 Lys were all synthesized 
using the same procedure. In scheme 1 the procedure used for the synthesis of mimochrome 
IV is depicted. Both solid phase and solution methods were used in the synthetic procedure. 
The deuteroporphyrin scaffolds was functionalized with three different peptides (figure 
4.1).. 
 
 
 
  
                                          R=R1; Mimochromes peptide 
 
 
 
 
 
 
 
  
 
Figure 4.1: Structure of  Fe-mimochrome IV 8Glu, Fe-mimochrome IV 8Lys and Fe-mimochrome IV 
 
 
The fully protected nonapeptide, except for the Lys residue, were synthesized by solid 
phase methodology. After removal of the peptides from the resin and deprotection of the 
Lys side chain, the peptide were coupled in solution to the porphyrin ring. Finally, the fully 
deprotection of protected group gave the desired molecules.  
 
Mimochrome Peptide sequence 
8Glu Ac-Glu-Glu-Glu-Leu-His-Glu-Glu-Lys-Arg-NH2 
8Lys Ac-Glu-Lys-Lys-Leu-His-Lys-Lys-Lys-Arg-NH2 
IV Ac-Glu-Ser-Gln-Leu-His-Ser-Asn-Lys-Arg-NH2 
1 
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Scheme 1:  General synthetic procedure for the synthesis of Mimochrome IV  
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4.2      Peptides synthesis 
 
The following peptides were synthesized: 
 
Mimochrome IV :              Ac-Glu1-Ser2-Gln3-Leu4-His5-Ser6-Asn7-Lys8-Arg9-NH2 
Mimochrome IV 8Glu :  Ac-Glu1-Glu2-Glu3-Leu4-His5-Glu6-Glu7-Lys8-Arg9-NH2 
Mimochorme IV 8Lys :  Ac-Glu1-Lys2-Lys3-Leu4-His5-Lys6-Lys7-Lys8-Arg9-NH2 
 
The peptides synthesis protocol was: 
 
1)  Automatic peptide synthesis, characterized by the following steps: 
• Deprotection of the α- Fmoc group 
• α-carboxyl group Activation 
• Coupling 
2)  Deprotection of the Lys ε-amino group 
3)  Cleavage from the resin 
 
The most difficult step of the mimochrome synthesis was the preparation of the 
nonapeptide fragment, protected at all functional groups except the ε-amino function of the 
Lys8 residue. 
The Sieber amide resin (shown in figure 4.2) was chosen for all three synthesized peptides, 
because it allows the cleavage of the peptide from the resin while leaving all protecting 
groups on the side-chains, as well as on the N-terminal residue, intact. 
 
 
 
                 
 
 
 
 
 
 
Figure 4.2: Sieber amide resin 
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Another fundamental point was the choice of the protecting group on N-ε function of the      
Lys8, since its removal conditions had to be different than for the other side chain 
protecting groups. The Mmt protecting group (figure 4.3) was chosen, since it can be easily 
removed by repeated treatments with a solution containing 10% acetic acid and 20% 
trifluoroethanol (TFE) (v/v) in CH2Cl2, without affecting the other protecting groups. 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Fmoc-Lys(Mmt)-OH 
 
For the synthesis of the three peptides the following amino acids were used:  
 
Mimochrome IV: Fmoc-Glu(OtBu)-OH, Fmoc-Ser(tBu)-OH, Fmoc-Gln(Trt), Fmoc-Leu-
OH, Fmoc-His(Trt)-OH, Fmoc-Asn(Trt)-OH, Fmoc-Lys(Mmt)-OH,  Fmoc-Arg(Pbf)-OH 
 
Mimochrome IV 8Glu : Fmoc-Glu(OtBu)-OH, Fmoc-Leu-OH, Fmoc-His(Trt)-OH,  Fmoc-
Lys(Mmt)-OH,  Fmoc-Arg(Pbf)-OH 
 
Mimochrome IV 8Lys : Fmoc-Glu(OtBu)-OH, Fmoc-Lys(Boc)-OH, Fmoc-Leu-OH, Fmoc-
His(Trt)-OH,  Fmoc-Lys(Mmt)-OH,  Fmoc-Arg(Pbf)-OH 
 
The three peptides were synthesized on a 0.25 mmol scale, using a 0.52 mmol/g resin 
substitution. After cleavage of the resin, the products were purified to homogeneity by RP-
HPLC.  
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4.2.1 Synthesis of mimochrome IV peptide 
 
As shown by the HPLC chromatogram (figure 4.4), after deprotection of the Mmt from 
Lys8 and after cleavage from the resin, two products are present, with retention times of 
26,00 min for species A and 28,50 min for species B, therefore the product required 
purification. The identity of the products was determined by mass spectroscopy:  
 
Mass compound A: 2063.62 Da (calculated 2284.0 Da). 
Mass compound B: 2304.62 Da (calculated 2284.0 Da).  
 
From analysis of the M/z ratio,  product B proved to be the desired nonapeptide + Na+, 
whereas  product A corresponded to the peptide without the Trt protecting group on His5 
residue . 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: HPLC chromatogram  of  mimochrome IV peptide 
 
The peptide was purified by RP-HPLC, after which the fractions containing the desired 
product were lyophilized  
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4.2.2 Synthesis of mimochrome IV 8Glu peptide 
 
As shown by the HPLC chromatogram (figure 4.5), after deprotection of the Mmt from the 
Lys8 and after cleavage from the resin, there are two main products with retention times of 
13,40 min for species A and 19,34 for species B, therefore also in this case the product 
required purification. As for mimochrome IV, the identity of the products was determined 
by mass spectroscopy:  
 
Mass compound A: 1793 (calculated 2014.0 Da). 
Mass compound B: 2036 Da (calculated 2014.0 Da).  
 
From the analysis of M/z ratio, product B, as expected, was the fully protected nonapeptide, 
+ Na+ , with only Lys8 residue deprotected. Product A, again, corresponded to the fully 
protected nonapeptide + Na+, except for the His5 and Lys8 residue.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: HPLC chromatogram  of  mimochrome IV 8Glu peptide 
 
The product was purified by RP-HPLC, after which the fractions containing the desired 
product were lyophilized.  
 
 
 
 
 
B A 
19,34 
13,40 
Minutes
0 10 20 30 40
m
AU
 
-250 
0 
250 
500 
m
AU
-250 
0 
250 
500 
          39 
Minutes
0 10 20 30 40
m
AU
-200
0
200
m
AU
-200
0
200
4.2.3 Synthesis of mimochrome 8Lys peptide 
 
As shown by the HPLC chromatogram (figure 4.6), after deprotection of the Mmt from 
Lys8 and after cleavage from the resin, there is one main product, with a retention time of 
25,90 min. The identity of the products was determined by mass spectroscopy. No further 
purification was required. 
 
Mass compound A: 2211 Da (calculated 2190 Da).  
 
From the analysis of M/z ratio, product A, as expected, was the fully protected nonapeptide 
+ Na+, with only Lys8 residue deprotected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: HPLC chromatogram  of  mimochrome IV 8Lys peptide 
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4.3 Peptide-deuteroporphyrin coupling 
 
The purified fully protected nonapeptides were coupled in solution to the deuteroporphyrin 
ring. In order to favour the formation of the bis sostituited deuteroporphyrin IX, the mixture 
of  activated porphyrin was slowly added to the nonapeptide solution. This approach has 
lead to a good average yield for all mimochromes.  
 
 
4.3.1 Coupling of mimochrome IV 
 
As shown by the HPLC chromatogram (figure 4.7), after the coupling reaction and the 
subsequent complete deprotection of the side chain protecting groups, there is one main 
product with retention time of  20,03 min. 
The identity of the product was checked by mass spectroscopy (figure 4.8), which 
confirmed the product to be mimochrome IV (mass: 2753,26, calculated 2753,57). 
Mimochrome IV was purified by HPLC. The pooled fractions containing the desired 
product were lyophilized  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: HPLC chromatogram  of  pure mimochrome IV free base 
 
 
21,18 
Minutes 
10 15 20 25 30 35 40 45 
m
AU
0 
25
50
75
20,03 
          41 
Minutes
10 20 30 40
m
AU
-50
0
50
100
2402 2650 2898 3146 
Mass (m/z) 
0 
2.4E+4 
2154 
20 
40 
60 
80 
100 
%
 
In
te
n
si
ty
 
2753 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: Mass spectrum of  mimochrome IV free base 
 
4.3.2 Coupling mimochrome IV 8Glu 
 
As for mimochrome IV, after coupling and deprotection by protecting groups, the HPLC 
chromatogram (figure 4.9) confirmed the presence of a main peak with a retention time of 
21,94 min. Mass spectroscopy (figure 4.10) confirmed the product to be mimochrome IV 
8Glu (mass: 2953 Da, calculated 2953 Da). 
Mimochrome IV 8Glu was purified with HPLC, the pooled fractions containing the desired 
product were lyophilized. 
 
 
 
 
 
 
 
 
 
 
Figure 4.9: HPLC chromatogram  of pure mimochrome IV 8Glu free base 
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Figure 4.10: Mass spectrum of  mimochrome IV 8Glu free base 
 
 
4.3.3 Coupling mimochrome IV 8Lys 
 
The same coupling procedure was also applied to Mimochrome IV 8Lys, which produced 
the same positive results as the others mimochromes. The HPLC chromatogram after 
deprotection (figure 4.11) of the side chain protecting groups showed one main peak, with 
retention time of 19,90 min. The identity of mimochrome IV 8Lys was confirmed by mass 
spectroscopy (mass 2948.26 Da, calculated 2948 Da) (figure 4.12). The product was 
purified by HPLC and lyophilized.  
 
 
 
 
 
 
 
 
  
Figure 4.11:  HPLC chromatogram  of pure mimochrome IV 8Lys free base 
19,90 
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Figure 4.12: Mass spectrum of  mimochrome IV 8Lys free base 
 
 
4.4 Iron insertion into mimochromes 
 
Basically, the reaction between the metal ion and a porphyrinic compound consists of a) the 
formation of the equatorial MN4 plane; and b) the completion of the axial coordination 
sphere. However, certain considerations have to be made concerning the metalation 
procedure:  
 
1. The solvent for the reaction should be able to dissolve the porphyrin as well as the 
metal compound, but without coordinating the metal ion with high affinity in order 
to avoid competition with the porphyrin. 
 
2. The porphyrin has to be deprotonated in order to produce the negative P2- ion that is 
present in the metal-porphyrin complex. The presence of strong acids in the reaction 
media will impede or even reverse metalation by shifting the protonation/ 
deprotonation equilibrium to the left.  
 
 
3. To be able to react with the porphyrin macrocycle, the metal compound which 
carries the metal ion should dissociate, yielding an active (coordinatively 
unsaturated) species. Therefore, the metal complex should not be too stable 
2945 
H4(P)2+             H3(P)+              H2(P)              H(P)–             (P)2– 
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otherwise it will not react with the porphyrin present in the reaction mixture. Other 
considerations are the availability, ease of handling, and solubility of the metal 
complexes in organic solvents. 
 
4. After the incorporation of a metal ion with a positive charge greater than +2, it will 
bind one or more anions from the reaction medium to form a neutral species. Some 
metal ions prefer certain defined geometries, which require the addition of a neutral 
ligand (solvent, H2O, O2) to complete their coordination sphere. 
 
The methods commonly used for the insertion of metal ions in the porphyrin macrocycle 
are listed below. The systems are characterized either by the solvent or the metal carrier 
used, depending on the more essential component. Since metalloporphyrins have 
characteristic UV-VIS properties, the reaction is usually monitored by spectrophotometry. 
 
The acetate method 
 
           Zn(OAc)2.xH2O + H2P                 Zn(P) + 2 HOAc + 2 H2O  
 
The acetate method includes all metalation reactions in which the protons of the porphyrin 
are transferred to acetate or propionate ions of the metal acetates/propionates. The solvents 
can be glacial acetic acid, or mixtures of CHCl3/MeOH. This method can be applied to all 
divalent metals, except those which are unstable in acetic acid, and to some tri- and 
tetravalent metal ions. Often sodium acetate is added to further buffer the solution and to 
enhance deprotonation of the porphyrins. This method is considered the method of choice 
for the synthesis of manganese-porphyrin complexes. 
 
The pyridine method 
 
          Mg(ClO4)2 + H2P  + 4 Py               Mg(P)Py2 + 2 [PyH][ClO4] 
 
In those cases where the metalloporphyrin is very labile towards acids, the basic solvent 
pyridine is used for divalent metal ions. Pyridine is capable of dissolving the porphyrins as 
well as the metal salts, and the good complexing properties of pyridine allow the direct 
isolation of metalloporphyrin pyridinates. The same properties, however, impede the 
HOAc 
 
50 ºC 
Py 
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incorporation of metal ions with higher charges by forming pyridine complexes with the 
metal carrier, thus retarding the dissociation of the metal ion. 
 
The dimethylformamide method 
 
                 4 CrCl4 + 4 H2P  + O2              4 Cr(P)Cl + 2 H2O + 4 HCl 
 
Weakly coordinating, high boiling oxygen-donor solvents such as dimethylformamide, 
tetramethylurea and sulfolan are excellent solvents for the metal carriers and porphyrins. 
The best results have been obtained with anhydrous metal chlorides (although they can be 
difficult to obtain and to handle), as the high boiling temperature forces the formed HCl to 
escape.  
 
The metal carbonyl method 
 
                Re2(CO)10 + H2P              [Re(CO)3]2(P) + H2 + 4 CO  
 
In metal carbonyls some of the CO groups may be eliminated, resulting in a coordinatively 
unsaturated species. This species acts as a Lewis acid, attacking the lone pairs of the 
porphyrin nitrogen atoms. This method is especially useful for the preparation of 
porphyrins containing the metals of groups VI to VIII.  
 
For the insertion of iron into mimochrome, the acetate method was used. The reaction took 
place in a 60/40 (v/v) solution of acetic acid and TFE, using iron(II) acetate as metal 
carrier. Upon insertion of the metal in the porphyrin ring, the Fe(II) ion was oxidized to 
Fe(III). During the reaction, the colour of the reaction mixture changed from red to brown, 
indicating the formation of the Fe(III) porphyrin complex. The reaction was monitored by 
HPLC and UV-vis spectroscopy. 
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4.4.1 Synthesis of Fe(III) mimochrome IV 
 
After two hours the reaction mixture turned slowly brown, and the HPLC chromatogram 
showed the presence of a new peak at 19.79 min with the characteristic UV spectrum of 
Fe(III) mimochrome (figure 4.13). The mass spectrum confirmed (figure 4.14) the identity 
of the desired product: 2805 Da (calculated 2806.0 Da). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13: HPLC chromatogram and UV-vis spectra, at pH ≈ 1, of mimochrome IV free base (a)  and 
Fe(III) mimochrome IV (b).   
 
 
 
 
 
 
 
 
Figure 4.14: Mass spectrum of Fe(III) mimochrome IV 
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4.4.2 Synthesis of Fe(III) mimochrome IV 8Glu 
 
The formation of the Fe(III)-complex of mimochrome 8Glu was analogue to the synthesis 
of Fe(III) mimochrome IV. The same colour change was observed and the HPLC 
chromatogram showed the presence of a new peak at 21,20 min with the characteristic UV 
spectrum of Fe(III) mimochrome (figure 4.15). The identity of the desired product was 
confirmed by mass spectroscopy. (mass: 3008 Da; calculated; 3008 Da ) (figure 4.16). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15: HPLC chromatogram and UV-vis spectra, at pH ≈ 1, of mimochrome IV 8Glu free base (a) and 
Fe(III) mimochrome IV 8Glu (b)    
 
 
 
 
 
 
 
Figure 4.16: Mass spectrum of Fe(III) mimochrome IV 8Glu 
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4.4.3 Synthesis of Fe(III) mimochrome IV 8Lys 
 
The same results were obtained for mimochrome IV 8Lys. The HPLC chromatogram 
showed the formation of a new compound with a retention time of  18.80 min, which 
showed the characteristic UV spectrum of Fe(III) mimochrome (figure 4.17). As for the 
other mimochromes, the identity of Fe(III) mimochrome IV 8Lys was confirmed by mass 
spectroscopy.  (mass: 3001 Da; calculated: 3001 Da) (figure 4.18). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.17: HPLC chromatogram and UV-vis spectra, at pH ≈ 1, of mimochrome IV 8Lys free base (a) and 
Fe(III) mimochrome IV 8Lys (b)    
 
 
 
 
 
 
 
Figure 4.18: Mass spectrum of Fe(III) mimochrome IV 8Lys 
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Chapter 5: Spectroscopic characterization of mimochromes 
 
5.1 UV-vis spectroscopy of mimochromes 
 
UV-vis spectroscopy was used to verify the metal insertion into the porphyrin ring, and to 
determine the coordination geometry of the metal ion in both Fe(III) mimochrome IV  8Glu 
and Fe(III) mimochrome IV 8Lys.  
 
 
5.1.1 UV-vis spectroscopy of Fe(III) mimochrome IV 8Glu  
 
Figure 5.1a and 5.1b shows the UV-vis spectrum of 3.05 x 10-5 M mimochrome IV 8Glu 
free base, and 6.76 x 10-6 M Fe(III) mimochrome IV 8Glu, in 10 mM phosphate buffer 
solution at pH 7, respectively. The observed spectral changes in both the Soret and visible 
regions, upon reaction of the free-deuteroporphyrin peptide conjugate with the metal ions, 
clearly denoted metal insertion into mimochrome IV 8Glu. The position and the relative 
intensities of the Soret, β and α bands give useful information on the metal ion coordination 
state76,95. The iron derivative at pH 7, is characterized by a band at 401 (ε = 9.67 x 104      
M-1cm-1), by a band at  522 nm (ε = 6.18 x 103 M-1cm-1) and a shoulder at  560 nm. This is 
an indication of a ferric low-spin state, with a bis-His axial coordination76, 95. All the 
spectral data are very similar to those found for Fe(III) mimochrome IV110. 
Table 5.1 reports the typical UV-vis parameters of Fe(III) mimochrome IV 8Glu and Fe(III) 
mimochrome IV. 
 
 
Table 5.1: Parameters are derived from the experimental UV-vis spectra recorded under the conditions 
indicated in the experimental section. (a), Data taken from ref.110. 
 
 
 
 
 
 ε(Soret) M-1 cm-1 Soret (nm) ε(β) M-1 cm-1 β and α  (nm) 
Fe(III)-mimochromeIV 8Glu 9.60 x 104          401  6.60 x 103       522 -560  
Fe(III)-mimochrome IVa 1.03 x 105          401  6.18 x 103       522 -560  
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Figure 5.1a:  UV-vis spectrum of 3.05 x 10-5 M mimochrome IV 8Glu free base, in 10 mM phosphate buffer 
at   pH 7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1b: UV-vis spectrum of 8.90 x 10-6 M Fe(III) mimochrome IV 8Glu, in 10 mM phosphate buffer     
at  pH 7. 
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5.1.2 UV-vis Fe(III) mimochrome IV 8Glu pH titrations 
 
 
The pH effect on the properties of Fe(III) mimochrome IV 8Glu was examined in aqueous 
solution by UV-vis spectroscopy. Figure 5.2 shows selected UV-vis spectra of Fe(III) 
mimochrome IV 8Glu at different pH (from pH 2 to 8). At pH ≈ 2 the spectrum is 
characterized by absorption maxima at 388, 494, 613 nm, for the Soret, β and α bands, 
respectively. This spectrum is in agreement with a high spin state for Fe(III) axially 
coordinated by two weak ligands (i.e., water molecules)95. In the pH range from 2 to 6  the 
Soret band is red shifted from 388 to 401 nm, while the visible bands at 522 and 560 nm 
appears with a simultaneous disappearance of the bands at 494 and 613 nm. At pH ≈ 8 the 
spectrum is characterized by absorption maxima at 401, 522, 560 nm, thus indicating the 
formation of a strong ligand field on the iron porphyrin, typical of a  bis-His coordination. 
The absence of an isosbestic point suggests that more species are involved in the 
equilibrium.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: UV-vis spectrum of 3.76 x 10-6 M Fe(III) mimochrome IV 8Glu, in  the Soret and visible region,  
at different pH (2-8). 
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Figure 5.3 reports the absorbance at 388 and 401 nm, as a function of pH. The experimental 
data could be fitted with two pKa values at pH 3.85 ± 0.4 and pH 5.03 ± 0.7 (see appendix 
A1). The first  pKa value represents, in comparison with Fe(III) mimochrome IV pH 
tritration110, the apparent pKa for the protonation of the axially coordinated histidines 
(pKapp), as defined by Kennedy et al.114. The Fe(III) imidazole complexes are know to be 
exchange-labile and therefore the observed pKa value accounts for the competition 
equilibrium between the coordination of the His to the iron and the protonation of the His 
in the uncoordinated form.  
The pKa2 of Fe(III) mimochrome IV 8Glu is difficult to interpret. It may be due to several 
protonation equilibrium of the glutammic acids that may somehow influence the geometry 
of the axial ligand.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 5.3: Plot of the absorbances a of 3.76 x 10-6 M Fe(III) mimochrome IV 8Glu at 401 (⁭) and              
388 (o)  nm as a function of  pH.  
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5.1.3 UV-vis spectroscopy of Fe(III) mimochrome IV 8Lys 
 
 
Figure 5.4a and 5.4b shows the UV-vis spectrum of 2.23 x 10-5 M mimochrome IV 8Lys 
free base and the UV-vis spectrum of 8.25 x 10-6 M Fe(III) mimochrome IV 8Lys,  in        
10 mM phosphate buffer solution at  pH 7, respectively. The observed spectral changes in 
both the Soret and visible regions, upon reaction of the free-deuteroporphyrin peptide 
conjugate with the metal ions, clearly denoted metal insertion into mimochrome IV 8Lys. 
The iron derivative at pH 7, is characterized by a band at 402 (ε = 1.01 x 105 M-1cm-1), by a 
band at  522 nm (ε = 6.60 x 103 M-1cm-1) and a shoulder at  560 nm. This is an indication of 
a ferric low-spin state, with a bis-His axial coordination76,95. All the spectral data are very 
similar to those found for  Fe(III) mimochrome IV110. 
Table 5.2 reports the typical UV-vis parameters of Fe(III) mimochrome IV 8Lys and  
Fe(III) mimochrome IV110. 
 
  
 
Table 5.2:  Parameters are derived from the experimental UV-vis spectra recorded under the conditions  
indicated in the experimental section. (a), Data taken from ref.110. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ε(Soret)  M-1 cm-1 Soret (nm) ε(β-band)  M-1 cm-1 β and α  (nm) 
Fe(III)-mimochromeIV 8Lys 1.01 x 105 402 6.60 x 103       522 -560  
Fe(III)-mimochrome IVa 1.03 x 105 401 6.18 x 103       522 -560  
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Figure 5.4a: UV-vis spectrum of 2.23 x 10-5 M mimochrome IV 8Lys free base, in 10 mM phosphate buffer 
at   pH 7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4b: UV-vis spectrum of 8.25 x 10-6 M Fe(III) mimochrome IV 8Lys, in 10 mM phosphate buffer at    
pH 7. 
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5.1.4 UV-vis Fe(III) mimochrome IV 8Lys pH titrations 
 
The pH effect on the properties of Fe(III) mimochrome IV 8Lys was examined in aqueous 
solution by UV-vis spectroscopy. Figure 5.5 shows selected UV-vis spectra of                                     
Fe(III) mimochrome IV 8Lys at different pH (from pH 2 to 8). At pH ≈ 2 the spectrum is 
characterized by absorption maxima at 388, 494, 613 nm, for the Soret, β and α bands, 
respectively. This spectrum is in agreement with a high spin state for the Fe(III), axially 
coordinated by two weak ligands (i.e., water molecules)95. In the pH range from 2 to 6  the 
Soret band is red shifted from 402 to 388 nm while in the visible bands appears at 522 and 
560 nm with a simultaneous disappearance of the bands at 494 and 613 nm. At pH ≈ 8 the 
spectrum is characterized by absorption maxima at 402, 522, 560 nm, thus indicating the 
formation of a strong ligand field on the iron porphyrin, typical of a  bis-His coordination.. 
The presence of an isosbestic point suggests that only two species may predominantly be 
involved in the equilibrium..   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5: UV-vis spectrum of 7.00 x 10-6  M  Fe(III) mimochrome IV 8Lys,  in  the Soret  and  visible   
region, at different pH (2-8)  
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Figure 5.6 reports the absorbance values at 402 and 388 nm, as a function of pH. Both 
titration curves exhibit one midpoint at pH 2.63 ± 0.03 (see appendix A2). The pKa value 
represents, in comparation with Fe(III) mimochrome IV pH titration110,  the apparent pKa 
for the protonation of the axially coordinated histidines (pKapp), as defined by Kennedy et 
al.114, similarly to what found for the first pKa of  Fe(III) mimochrome IV 8Glu 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6:  plot of the absorbance of 7.00 x 10-6 M Fe(III) mimochrome IV 8Lys, at 402 (⁭) and                 
388 (o)  nm, as a function of the pH. 
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5.2 Circular dichroism spectroscopy of mimochromes 
 
CD measurements in both the UV and Soret regions gave preliminary structural 
information on Fe(III) mimochrome IV 8Glu and Fe(III) mimochrome IV 8Lys. CD spectra 
for all the mimochromes were recorded in both far-UV and Soret regions, using a 
trifluoroethanol (TFE) /water solution as solvent.  
 
5.2.1 Circular dichroism spectroscopy of Fe(III) mimochrome IV 8Glu 
 
The 190–260 nm spectrum of Fe(III) mimochrome IV 8Glu in 10mM phosphate buffer at 
pH 7 (solid red line in figure 5.7) is characterized by double minima at 222 and 203 nm and 
a maximum below 190 nm. The [θ] value at 222 nm, the [θ]ratio and the λο indicate the 
presence of a low helical content. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7:  CD spectra of 5.36 x 10-6 M Fe(III) mimochrome IV 8Glu in the far-UV region, phosphate buffer 
(10 mM, pH 7.0) with 0%, 15%, 30% TFE content. 
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The addition of the structure inducing solvent TFE results in an small increase of the helical 
content for both species as expected.  
 
 
 
 
 
 
 
 
Figure 5.8:  Plot of the [θ]
 
value at 222 nm for Fe(III) mimochrome IV 8Glu as a function of the TFE 
concentration . 
 
 
 
 
 
 
 
 
 
 
Table 5.3: CD parameters of Fe(III) mimochrome IV 8Glu and Fe(III) mimochrome IV, in 30% 
TFE/phosphate buffer (10mM, pH 7.0). [a], [θ] are expressed as mean residue ellipticities      
(deg cm2dmol-1 res-1) in the UV region; λ is expressed in nm; [θ]min represents the ellipticity at 
the shorter wavelength minimum; [θ]ratio represents the ratio of the ellipticity at 222 nm to that 
at the shorter wavelength minimum. [b] Data taken from ref.110.  
 
 
 
 
 
 
           Species 
 
[θ]min x10-3(a) 
(λ, nm) 
[θ]222 x10-3 [θ]ratio(a) λ0(nm) 
Fe(III)-Mimochrome IVb -11,20 (207) -9,54 0,85 200,1 
Fe(III)-Mimochrome IV 8Glu -16,55 (204) -5,76 0,35 195,8 
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The CD spectrum of Fe(III) mimochrome IV 8Glu was also recorded in the Soret region 
(Figure 5.9). It is characterized by the presence of a positive Cotton effect in the Soret 
region, with a maximum at 395 nm. We hypothesize that Fe(III) mimochrome IV 8Glu 
adopts a Λ configuration on the basis of the CD spectrum of  Fe(III) mimochrome IV110. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9:  CD spectrum of 5.36 x 10-6 M Fe(III) mimochrome IV 8Glu in the Soret region (phosphate 
buffer 10 mM, pH 7.0). 
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5.2.2 Circular dichroism pH titration of Fe(III) mimochrome IV 8Glu 
 
We studied the effect of pH (from 2 to 8) on the secondary structure of Fe(III) mimochrome 
IV 8Glu (see figure 5.10). Figure 5.11 reports the plot of the 222 nm band intensity as a 
function of  pH. The intensity of the [θ] value at 222 nm increases by raising the pH, with a 
midpoint transition at pH 5.6. This value is close to the second midpoint transition   
observed in the UV-vis titration (pKa2= 5.03).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 5.10 : CD spectra of 6,82 x10-6 M Fe(III) mimochrome IV 8Glu in the far-UV region at pH 7.80 
(solid red line) and  pH 3.60 (solid green line). 
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Figure 5.11:  Plot of the [θ] value at 222 nm, for 6,82 x10-6 M Fe(III) mimochrome IV 8Glu, as a function of 
the pH. 
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5.2.3 Circular dichroism spectroscopy Fe(III) mimochrome IV 8Lys 
 
The 190–260 nm spectra of Fe(III) mimochrome IV 8Lys in 10mM phosphate buffer at   
pH 7, (red line solid figure 5.12) are characterized by double minima at 222 and 203 nm 
and a maximum below 190 nm. The [θ] value at 222 nm, the [θ]ratio and the λο in aqueous 
solution, indicate the presence of a low helical content. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12: CD spectra of 3,36 x 10-6 M Fe(III) mimochrome IV 8Lys in the far-UV region, phosphate 
buffer (10 mM, pH 7.0) with 0%, 15%, 30% TFE content. 
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The addition of TFE results in an increase of the helical content as expected (figure 5.13).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.13:  Plot of the [θ] value at 222 nm, for Fe(III) mimochrome IV 8Lys, as a function of the TFE 
concentrations . 
 
 
 
 
 
 
 
 
 
 
 
Table 5.3: CD parameters of Fe(III) mimochrome IV 8Glu and Fe(III) mimochrome IV, in 30% 
TFE/phosphate buffer (10mM, pH 7.0). [a], [θ] are expressed as mean residue ellipticities      
(deg cm2dmol-1 res-1) in the UV region; λ is expressed in nm; [θ]min represents the ellipticity at 
the shorter wavelength minimum; [θ]ratio represents the ratio of the ellipticity at 222 nm to that 
at the shorter wavelength minimum. [b] Data taken from ref. [5a].  
 
 
 
The CD spectrum of Fe(III) mimochrome IV 8Lys was recorded in the Soret region (figure 
5.14). It is characterized by the presence of a positive Cotton effect in the Soret region, with 
a maximum at 396 nm. 
 
           Species 
 
(θ)min x10-3(a) 
(λ, nm) 
(θ)222 x10-3 (θ)ratio(a) λ0(nm) 
Fe(III)-Mimochrome IVb -11,20 (207) -9,54 0,85 200,1 
Fe(III)-Mimochrome IV 8Lys -14,78 (206) -9,87 0,67 198,1 
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We hypothesize that Fe(III) mimochrome IV 8Glu adopts a Λ configuration on the basis of 
the CD spectrum Fe(III) mimochrome IV110. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.14:  CD spectrum of 3.36 x 10-6 M Fe(III) mimochrome IV 8Glu in the Soret region. (phosphate 
buffer 10 mM, pH 7.0). 
 
 
 
 
 
 
 
 
 
 
 
 
 
          65 
5.2.4  Circular dichroism  pH titration of Fe(III) mimochrome IV 8Lys 
 
We studied the effect of pH (from 2 to 8) on the secondary structure of Fe(III) mimochrome 
IV 8Lys (see figure 5.15). Figure 5.16 reports the plot of the 222 nm band intensity as a 
function of  pH. No significant spectral changes are observed by raising of pH. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15 : CD spectra of  8.44 x10-6 M Fe(III) mimochrome IV 8Lys in the far-UV region at pH 7.80 
(solid red line) and  pH 3.80 (solid green line).  
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Figure 5.16 : Plot of the 222 nm band intensity, for 8.44 x 10-6 M  Fe(III) mimochrome IV 8Lys, as a  
function of the pH  
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5.2.5 Circular dichroism  pH titration of Fe(III) mimochrome IV 
 
We also studied the effect of pH (from 2 to 8) on the secondary structure of Fe(III) 
mimochrome IV  (see figure 5.17). Figure 5.18 reports the plot of the 222 nm band 
intensity as a function of the pH. The intensity of the [θ] value at 222 nm decreases up to 
pH 5 for then no change to pH above 5 (see figure 5.18). The same behavior was found for 
CD pH titration of Fe(III) mimochrome IV in the Soret region110. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.17 : CD spectra of  9,68 x10-6 M Fe(III) mimochrome IV in the far-UV region as a function of pH, 
at pH 7.20 (solid red line) and  pH 4.95  (solid green line). 
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Figure 5.18:  Plot of the 222 nm band intensity, for 9.68 x 10-6 M Fe(III) mimochrome IV, as a function of 
the pH. 
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Chapter 6: Square-Wave Voltammetry of Fe mimochromes 
 
Square wave voltammetry experiments was performed in collaboration with the research 
group of professor Marco Borsari and Marco Sola at the University of Modena. 
 
6.1 Square-Wave Voltammetry of Fe mimochrome IV 8Glu 
 
The FeIII/FeII reduction potential (E˚’) of Fe-mimochrome IV 8Glu, was determined by       
Square-Wave Voltammetry (SWV) using a pyrolytic graphite electrode, at 25 C˚. 
Figure 6.1a and 6.1b show the voltammograms of Fe-mimochrome 8Glu, obtained with  
cathodic and anodic scans, in 10mM phosphate buffer  at pH 7, and NaClO4 100 mM. They 
show a well-behaved voltammetric wave in both scans. A redox potential of -170 mV, 
versus the hydrogen electrode (SHE), could be evaluated from the experimental data. 
This potential value is the mean between the maximum currents during cathodic and anodic 
scans. 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 6.1a: Square wave voltammogram; cathodic scan of Fe-mimochrome IV 8Glu  (25 ˚C, scan rate           
50 mVs-1), over a potential range between  0.2 and -0.8 V (against SCE), at pH 7.0  
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Figure 6.1b:  Square wave voltammogram; anodic scan of Fe-mimochrome IV 8Glu (25 ˚C, scan rate            
50 mVs-1), over a potential range between 0.2 and -0.8 V (against SCE), at pH 7.0  
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6.2 Square-Wave Voltammetry of Fe mimochrome IV 8Lys 
 
 
The FeIII/FeII reduction potential (E˚’) of Fe-mimochromes IV 8Lys, was determined by       
Square-Wave Voltammetry (SWV) using a pyrolytic graphite electrode, at 25 C˚. 
Figure 6.2a and 6.2b show the voltammograms of Fe-mimochrome 8Lys obtained with 
cathodic and anodic scans in 10mM phosphate buffer  at pH 7, and NaClO4 100 mM. They 
show a well-behaved voltammetric wave in both scan. A redox potential of -48 mV, versus 
hydrogen electrode (SHE), could  be evaluated from the experimental data.  
This potential was the mean values between the maximum currents during cathodic and 
anodic scans. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 6.2a: Square wave voltammogram; catodic scan of Fe-mimochrome IV 8Lys  (25 ˚C, scan rate           
50 mVs-1), over a potential range between 0.2 and -0.8 V (against SCE), at pH 7.0  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2b: Square wave voltammogram; anodic scan of Fe-mimochrome IV 8Lys (25 ˚C, scan rate             
50 mVs-1), over a potential range between 0.2 and -0.8 V(against SCE), at pH 7.0  
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6.3 Square-Wave Voltammetry of Fe mimochrome IV  
 
The FeIII/FeII reduction potential (E˚’) of Fe-mimochrome IV, was determined by       
Square-Wave Voltammetry (SWV) using a pyrolytic graphite electrode, at 25 C˚. 
Figure 6.3a and 6.3b shows the voltammograms, in cathodic and anodic scan, of              
Fe-mimochrome IV in 10mM phosphate buffer  at pH 7, and NaClO4 100 mM. They show 
two peaks for both scans. These peaks are characterized by differences in the maximum of 
current intensities that occur at quite different potentials. Usually the contribution of faradic 
current of adsorbed species is lower then that of the free specie in solution. Therefore the 
redox potential was determined on the first peak. By taking the mean currents by cathodic 
and anodic scan we have found a potential of -58 mV, versus  hydrogen electrode (SHE), 
was calculated as the mean value of the cathodic and anodic scans. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
 
 
 
Figur 6.3a:  Square wave voltammogram; cathodic scan of Fe-mimochrome IV  (25 ˚C, scan rate  50 mVs-1), 
over a potential range between 0.2 and -0.8 V against SCE, at pH 7.0.  
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 Figur 6.3b:  Square wave voltammogram; catodic scan of Fe-mimochrome IV  (25 ˚C, scan rate 50 mVs-1), 
over a potential range between 0.2 and -0.8 V against SCE, at pH 7.0.  
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Chapter 7: Discussion 
 
Several strategies were conceived to obtain metalloprotein models95,115,116. For heme-
protein models, the use of two parts that associate around the heme, to give folded covalent 
or non-covalent self-assembled dimers was particularly successful95,117. Numerous models 
are homo-dimers with C2 symmetry related components. The use of the symmetry is quite 
advantageous, on one hand, because it simplifies the design, the synthesis and the structural 
characterization, but, on the other hand it may lead to diastereomeric forms108. This 
problem was encountered in the study of mimochromes91,92. In fact, stable Λ and ∆ isomers 
of Co(III) mimochrome I were unpredicted, but experimentally observed. One possible 
solution to this problem came from the study of mimochrome IV. It contains a modified 
sequence of mimochrome I: Leu1 and Leu9 were substituted with Glu and Arg residues at 
position 1 and 9, respectively. This strategy was successful in stabilizing the sandwich 
structure and in favouring the formation of the Λ isomer only110. On the basis of this result 
two new mimochromes were developed. Fe(III) mimochrome IV 8Glu and Fe(III) 
mimochrome IV 8Lys are characterized by a sequence containing eight Glu residues and 
eight Lys residues, respectively (see figure 7.1). This new compounds allowed us to 
correlate the different charge distributions with the redox  properties of metal centre.  
 
 
 
                                            R=R1; Peptide mimchromes 
 
 
 
 
 
 
 
 
Figure 7.1: Structure of  Fe-mimochromes  
Mimochrome Sequence 
   8Glu Ac-Glu-Glu-Glu-Leu-His-Glu-Glu-Lys-Arg-NH2 
8Lys Ac-Glu-Lys-Lys-Leu-His-Lys-Lys-Lys-Arg-NH2 
IV Ac-Glu-Ser-Gln-Leu-His-Ser-Asn-Lys-Arg-NH2 
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First we studied the overall structure of both compounds in solution by UV-vis and circular 
dichroism spectroscopy with different experimental conditions.. The UV-vis spectra of both 
Fe(III) mimochrome IV 8Glu (Figure 5.1a and 5.1b) and Fe(III) mimochrome IV 8Lys 
(figure 5.4a and 5.4b), at pH 7, are typical of octahedral bis-His low spin complexes, in  
good agreement with the spectral features previously observed for Fe(III) mimochrome I 
and Fe(III) mimochrome IV. Bis-His coordination occurs for Fe(III) mimochrome IV 8Lys 
even at very acidic conditions. Both imidazoles of the axially coordinating His residues 
display a pKapp=2.67, indicating that the bis-His coordination to the iron represents over 
90% of the population at pH > 3.85 (Figure 5.6). The low pKa value of the axially 
coordinating His (with values very close to what observed in several myoglobins, 
hemoglobins and cytochromes in the oxidized and reduced forms) strongly supports the 
designed sandwich structure as for Fe(III) mimochrome IV complex119,120. For Fe(III) 
mimochrome IV 8Glu, in the pH range 2-8, a different behavior was observed. Two 
simultaneous equilibria (figure 5.2) were observed. The pKa1 (3.85) is attributed to the 
protonation of the His in the uncoordinated form, as already seen for the other 
mimochromes, the second pKa (5.03) is more difficult to interpret. It may be due to several 
protonation equilibrium of the glutammic acids that may somehow influence the geometry 
of the axial ligand.  
pH titrations also were followed by CD spectroscopy  in the UV region, in order to 
determine the effect of the overall charge distribution on the secondary structure. No 
significant changes are observed in secondary structure in the pH range from 5 to 8, for 
Fe(III) mimochrome IV (figure 5.17) and Fe(III) mimochrome IV 8Lys (figure 5.15). This 
result is consistent with no substantial charge distribution changes during the titration for 
both species. For Fe(III) mimochrome IV at pH values below 5, protonation of the His side 
chain takes place110(figure 5.18), as a consequence, the helical content decreases. 
Conversely no significant changes in the secondary structure are observed for Fe(III) 
mimochrome IV 8Lys at pH values below 5 (figure 5.16). 
The CD spectroscopic pH titrations of Fe(III) mimochrome IV 8Glu (figure 5.10) show that 
the [θ] value at 222 nm increases from pH 2 to 8. This behavior may be attributed to 
deprotonation of the glutamate side chains. This may imply fewer inter and/or intra-chain         
unfavourable charge interactions, and as a consequence the helical content increases. The 
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mid-point value was observed at pH 5.8. A similar value was also derived from the Pka2 of 
UV-vis pH titration of Fe(III) mimochrome IV 8Glu, this finding could indicate that both 
the Pka of CD and UV-vis spectroscopy pH titration refer to the same phenomenon.  
CD measurements in both the UV and Soret regions gave preliminary structural 
information on Fe(III) mimochrome IV 8Glu (see figure 5.7) and Fe(III) mimochrome IV 
8Lys (see figure 5.12). Analysis of the UV region indicates the peptides to be in helical 
conformation, in both Fe(III) mimochrome IV 8Glu and Fe(III) mimochrome IV 8Lys 
complexes at pH 7. The helical content increases upon TFE addition for Fe(III) 
mimochrome IV 8 Lys (Figure 5.12), reaching a maximum at 30% TFE quite similar to that 
observed for Fe(III) mimochrome IV110. The  helical content increases only slightly upon 
TFE addition for Fe(III) mimochrome IV 8Glu (figure 5.7). The helical content is lower 
then that observed for  Fe(III) mimochrome IV 8Lys and Fe(III) mimochrome IV.  
The CD spectra in the Soret region are very interesting, in order to correlate the sign of the 
Cotton effect with the configuration around the metal ion. Both Fe(III) mimochrome IV 
8Glu (figure 5.8) and Fe(III) mimochrome IV 8Lys (figure 5.14) exhibit positive Cotton 
effects. This finding, similarly to what found for Fe(III) mimochrome IV indicates that both 
systems adopt a Λ configuration110. The single positive Cotton effect gives a further 
indication on inter-helical interactions that reinforce the sandwich structure and drive the 
peptide chains to fold in a unique topology around the deuteroheme. 
The effect of the charge distributions on redox properties of metal centre, was determined 
by experiments of square wave voltammetry. The deuteroheme redox potential of             
Fe-mimochromes, at pH 7, are the following: 
 
Fe-mimochrome IV 8Glu: -170 mV vs SHE 
                                       Fe-mimochrome IV:           -58 mV vs SHE 
Fe-mimochrome IV 8Lys:   -48 mV vs SHE 
 
E°’Fe-mimohrome IV8glu <  E°’Fe-mimochrome IV  < E°’ Fe-mimochrome IV 8 Lys 
 
The square wave voltammograms, in cathodic and anodic scans, show for Fe-mimochrome 
IV 8Glu (figure 6.1a and 6.1b), Fe-mimochrome IV 8Lys (figure 6.2a and 6.2b) and          
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Fe-mimochrome IV (figure 6.3a and 6.3b), a well-behaved voltammetric wave in both 
scans. Fe-mimochrome IV voltammograms show the presence of a second peak, probably 
due to the electronic transfer of an adsorbed specie on the electrode. However a second 
species can not be ruled out.  
The redox potential of -170 mV for Fe-mimochrome IV 8Glu and -48 mV for Fe-
mimochrome IV 8Lys demonstrate that negatively charged residues, as for Fe-mimochrome 
IV 8Glu,  around the molecular core, stabilize the ferric deuteroheme, while the positively 
charged residue of Fe-mimochrome IV 8Lys stabilize the ferrous deuteroheme. This 
hypothesis was further confirmed from the redox potential of the parent Mimochrome IV   
(-58 mV), that is intermediate between that Fe-mimochrome IV 8Glu and Fe-mimochrome 
IV 8Lys.  
The small difference in the redox potential between Fe mimochrome IV and Fe 
mimochrome IV 8Lys may be due to the presence of  organized phosphate ions around the 
molecule. Phosphate ions are know to interact with the superficial lysines of cytochrome, 
even at low phosphate concentrations120,121. Therefore the net charge on Fe mimochrome 
IV 8Lys is partially neutralized by specific phosphate ion interactions. It will be interesting  
to estimate, the changes in the redox potentials due to different buffers and ionic strength. 
These redox potential values of mimochromes are significantly more positive than the 
reduction potential  of  bis-imidazole-ligated heme, as Fe(protoporphyrin IX)(Im)2, -235 
mV vs SHE, or Fe(mesoporphyrin IX)(Im)2, -285 mV vs SHE. This result would suggest 
that the sandwich structure of mimochromes decreases solvent exposure, thus lead ions to 
positive shifts of the reduction potential. 
In summary, Fe-mimochrome IV 8Glu and Fe-mimochrome IV 8Lys are a simple, 
structurally defined deuteroheme protein model, which may provide an excellent 
opportunity for exploring the subtle mechanisms that control the redox properties of the 
heme in natural proteins. 
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Chapter 8: Experimental section 
 
8.1 Design 
 
Molecular design was performed on a Silicon Graphic 2 workstation. The program package  
Insight/Discover with Exstensible Systematic Force Field (ESFF), was used for energy 
minimization and restrained molecular dynamic (RMD) simulation. The NMR structure of 
Co(III) mimochrome IV were used as template for modelling the mimochrome IV 8Glu and 
mimochrome IV 8Lys molecules. 
 
8.2 Equipment and materials 
 
All amino acids, the Sieber amide resin, HATU, HOBt and HBTU were purchased from 
Nova Biochem; piperidine, and scavengers were from Fluka. DIEA and TFA from Applied 
Biosystems. All solvents used in the peptide synthesis and purification were anhydrous and 
HPLC grade respectively, and were supplied by LabScan Analytica. Deuteroporphyrin IX 
was from Porphyrin Products. Iron(II) acetate and tetramethylsilane were from Aldrich. 
Solvent mixtures are indicated in the respective sections.  
 
 
8.3 Synthesis of Mimochrome peptides 
 
Mimochrome IV, mimochrome IV 8Glu, and mimochrome IV 8Lys peptides were 
synthesized using  Fmoc solid phase peptide synthesis (SPPS) on ABI 433 automatic 
peptide synthesizer on a 0.25 mmol scale. The used resin was the super acid labile Sieber 
Amide (100-200 mesh, 1% DVB, substitution level 0.52 mmol/g). For the synthesis of the 
three peptides the following amino acids were used:  
 
Mimochrome IV: Fmoc-Glu(OtBu)-OH, Fmoc-Ser(tBu)-OH, Fmoc-Gln(Trt)-OH,    Fmoc-
Leu-OH, Fmoc-His(Trt)-OH, Fmoc-Asn(Trt)-OH , Fmoc-Lys(Mmt)- OH, Fmoc-Arg(Pbf)-
OH 
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Mimochrome IV 8Glu: Fmoc-Glu(OtBu)-OH, Fmoc-Leu-OH, Fmoc-His(Trt)-OH, Fmoc-
Glu(OtBu)-OH, Fmoc-Lys(Mmt)-OH,  Fmoc-Arg(Pbf)-OH 
 
Mimochrome IV 8Lys :   Fmoc-Glu(OtBu)-OH, Fmoc-Lys(Boc)-OH, Fmoc-Leu-OH, 
Fmoc-His(Trt)-OH, Fmoc-Lys(Mmt)-OH,  Fmoc-Arg(Pbf)-OH 
 
For all peptides  the same synthetic procedures were used (see scheme 1  pages 31 and 32). 
The first step was the synthesis of  the fully protected peptides. This synthesis were 
achieved on a ABI 433 peptide synthesizer, with the Fmoc-chemistry. The synthetic 
procedure can be summarized as follow.  
The α- Fmoc group, is removed at the beginning of every cycle with a 20% piperidine 
solution. After deprotection, the resin is washed with NMP to remove the piperidine. The 
peptide resin is then ready for coupling. All amino acids were coupled using            a 0.45 
M HBTU/HOBT solution in DMF. In the coupling step, the activated Fmoc aminoacid 
reacts with the amino-terminal of the growing peptide chain to form a peptide bond. 
Deprotection and coupling steps are repeated with each subsequent amino acid, until the 
chain assembly has been completed When the coupling is complete, the resin is washed 
with NMP. Mimochrome peptide N-terminal amino groups were acetylated with acid acetic 
(1mmol, 57 µl). 
After the final assembly on the resin, the N-ε Mmt protecting group of the Lys8 residue was 
removed with repeated treatments of a solution containing 10% acetic acid and 20% 
trifluoroethanol (TFE) in CH2Cl2 (10 ml) for 15min. Each step was repeated until no yellow 
or red trityl cations were detected in eluent . The product thus obtained, was transferred  
into a reactor, to cleavage the resin from the peptide. Therefore was added 1%TFA  in 
DCM (20 ml) at the protected peptide. The mixture acid was shake for 2 minutes doing 
bubbling nitrogen. The solution was filtered, applying nitrogen pressure, into a flask 
containing 10% pyridine in methanol (2ml). The reaction was followed by TLC, each step 
was repeated until no product was detected. The side chain protecting groups were found to 
be stable in both deprotection reactions  
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8.4 Purification of mimochrome peptides 
Mimochrome IV and mimochrome IV 8Glu peptide crude materials  were purified by RP-
HPLC (Shimadzu LC-8A, equipped with a SPD-M10 AV detector), on a Vydac C18 column 
(5 x 25 cm; 10 µm), eluted with water-acetonitrile (both containing 0.1 % v/v TFA) linear 
gradient: 
 
• from 50 % to 90% acetonitrile concentration in 58 min; flow rate 120 ml/min  
 
The pooled fractions containing the desired products were lyophilized. The peptides were 
found to be homogeneous by analytical RP-HPLC (Shimadzu LC-10 AD, equipped with a 
SPD-M10 AV detector and a SIL-10A Auto Sampler; Vydac C18 column 0.46 x 15 mm, 
5µm), showing  the following retention times:   
 
                            mimochrome IV peptide:               28,50 min (figure 3.4), 
mimochrome IV 8Glu peptide:      19,34 min (figure 3.6), 
 
The purified compounds were analyzed by MALDI mass spectrometry (MALDI/MS) using 
a Voyager DE instrument (Perkin Elmer), operating at the Centro di Metodologie Chimico-
Fisiche, University Federico II of Napoli. The α-cyano-4-hydroxycinnamic acid matrix was 
recrystallized from EtOH on a Kromasil C18 column. The analysis of mass spectroscopy 
confirmed  the expected molecular weight 
From analytical RP-HPLC analysis the mimochrome IV 8Lys peptide (figure 3.7) was pure 
and did not require further purification. The peptide  mixture  was evaporated to dryness 
and the mass spectroscopy confirmed the expected molecular weight. Mimochrome IV 
8Lys peptide showing a retention time of 25,90 minutes. 
The yield of reaction are the followings: 
  
mimochrome IV:                  538 mg of  pure product (94%) 
mimochrome IV 8Glu:         315 mg  of pure product (63%) 
                          mimochrome IV 8Lys:         494  mg of pure product (90%) 
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8.5 Coupling of mimochromes 
 
Peptide synthesis protocols usually employ activants such as PyBop, DCC, HOBt, HATU, 
or HBTU in the presence of DIEA, to activate the free carboxyl groups and perform the 
coupling reaction to the next amino acid. The coupling reaction between the carboxyl 
groups of the porphyrin scaffols and the free ε amino groups of Lys8 was achieved by using 
HATU as activant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.1: schematic representation of mimochrome coupling. The figure refers to the coupling of  
mimochrome IV. 
 
The coupling was done in DMF at room temperature, at concentration of 6.6 x 10-3 M,  and 
it was effected in the same conditions for the three mimochromes . 
The first step was the deuteroporphyrin activation (Figure 8.2). The solid deuteroporphyrin 
IX dihydrocloride (1 equivalent, M.W., 583.5 g/mol), was dissolved in a small volume of 
DMF and DIEA (2 equivalents, M.W., 129,24 g/mol; density, 0.742 g/mL). At this solution 
were added 2 equivalents of HATU (M.W., 380.23 g/mol) and other 2 equivalents of 
DIEA, and this mixture was allowed to react for 15 min (figure 8.2).  
In a following step, the activated deutheroporphyrin was added to a solution containing the 
peptide (3 equivalents; M.W. mimochrome IV, 2284 g/mol; M.W. mimochrome IV 8Glu, 
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2014 g/mol; M.W. mimochrome IV 8Lys, 2190 g/mol) in DMF and DIEA (3 equivalents), 
to form mimochromes. Other DIEA was added till pH ~ 7/8.   
 
 
 
 
 
 
 
 
 
 
 
Figure 8.2: Schematic representation of deutheroporphyrin IX activation  
 
In order to favour the formation of the bis substituted deutheroporphyrin IX, the mixture of 
the activated porphyrin was slowly added to the solution of the nonapeptide. This approach 
gave a good average yield for all mimochromes. The table 8.1 reports the amounts of each 
reagents used in the coupling reaction. 
 
 
Table 8.1:  kinds and quantity of reagents used in the coupling reaction  
 
The proceeding of the reaction was followed by RP-HPLC on a Vydac C18 column             
(5 x 25 cm; 10 µm). After completion of the reaction, usually after 24 hours, the mixture 
was evaporated to dryness and extracted with chloroform and acid water (using citric acid 
Reaction coupling 
Deuteroporphyrin 
dihydroclhoride, 1eq 
Peptide, 3eq HATU, 2eq DMF 
mimochrome IV 
9.10  x 10-3g, 
1.56  x 10-5mol 
0.100 g, 
4.70 x 10-5mol 
1.19 x 10-2g, 
3.12 x 10-5mol 
2.35 ml 
mimochrome IV 8Glu 
1.17  x 10-2g, 
2.00  x 10-5mol 
0.120 g, 
6.00 x 10-5mol 
1.52 x 10-2g, 
4.00 x 10-5mol 
3.00 ml 
mimochrome IV 8Lys 
1.59  x 10-2g, 
2.73  x 10-5mol 
0.180 g, 
8.20 x 10-5mol 
1.69 x 10-2g, 
4.46 x 10-5mol 
4.10 ml 
NH
N NH
N
O O
PF
O
N
N
+O
N
+
N
PF6
-
PF6
-
NH
N NH
N
OOH O OH
N
N
NN
O
N
N
+
PFPF6
-
deutheroporphyrin IX 
HATU 
1 eq  2 eq  +  4eq DIEA 
Active 
Product 
DMF 
          84 
10% p/v) to eliminate the reagents (DIEA, HATU and the peptide). After completion of the 
extraction, the chloroform phase was evaporated. The next step was the deprotection of the 
protecting groups. It was achieved at room temperature in the following mixture: 
 
   9.40 ml   trifluoroacetic acid (TFA) 
   0.25 ml  ethanedithiol (EDT) 
   0.25 ml   water  
   0.10 ml   triisopropylsilane (TIS) 
 
The thiol-based scavengers were added to avoid any side reactions that might occur when 
the protecting groups were removed from the peptide side chains. For all compounds, the 
deprotection was usually complete in 2 h. After completion of the reaction, the solvent that 
contained the crude product was evaporated under reduced pressure to 5% of the volume. 
Ice-cold diethyl ether added to the residue and the mixture was cooled on ice to aid 
precipitation of the crude product. It was isolated from the remaining part of the scavengers 
by centrifuges with diethyl ether, and it was further purified by HPLC. (Shimadzu LC-8A, 
equipped with a SPD-M10 AV detector), on a Vydac C18 column (2.2 x 25 cm; 10 µm), 
eluted with water-acetonitrile (both containing 0.1 % v/v of TFA) linear gradient: 
 
• from 5 % to 90% acetonitrile concentration in 66 min; flow rate 22 ml/min  
 
The pooled fractions containing the desired products were lyophilized to obtain: 
 
mimochrome IV:                 35 mg of  pure product (53%) 
mimochrome IV 8Glu:        52 mg  of pure product (63%) 
                           mimochrome IV 8Lys:        54 mg of pure product (40%) 
 
The purified compounds were analyzed by MALDI mass spectrometry (MALDI/MS) using 
a Voyager DE instrument (Perkin Elmer), operating at the Centro di Metodologie Chimico-
Fisiche, University Federico II of Napoli. The α-cyano-4-hydroxycinnamic acid was 
recrystallized from EtOH on a Kromasil C18 column.  
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8.6   Insertion of Iron in Mimochromes 
 
For the insertion of iron acetate method was used .  
 
           Fe(OAc)2.xH2O + H2P                    Fe(P) + 2 HOAc + 2 H2O  
 
Iron II acetate (10 equivalent, M.W. 173,94) was added to a solution of pure mimochrome 
(M.W. mimochrome IV, 2753 g/mol, M.W. mimochrome IV 8Glu, 2953 g/mol; M.W. 
mimochrome IV 8Lys, 2945 g/mol)  in acetic acid/TFE (6:4) for a final concentration of      
2 x 10-4 M (figure 8.3). The reaction mixture was heated under reflux for 2 h at 45 °C. 
 
 
 
 
 
 
 
Table 8.2: iron insertion stecheometry; (a), molecular weight of TFA salt 
 
Upon insertion of the metal in the porphyrin ring, the FeII ion was oxidized to FeIII. During 
the reaction the colour of the reaction mixture changed from purple rose to brown, 
indicating the formation of the iron (III) porphyrin complex. The reaction was monitored 
by RP-HPLC and UV-VIS, where the characteristic FeIII-porphyrin spectrum became 
dominant. The desired product was purified to homogeneity by Gel fitration with pre-
packed PD-10 columns of the GE Healthcare Bio-Science AB (SephadexTM G-25M 
contains 0.15% Kathon CG as preservative). MALDI/MS confirmed the expected 
molecular weight (cap 3.1). The pooled fractions containing the desired products were 
lyophilized to obtain: 
                            
                             mimochrome IV  :             26mg of product pure (55%) 
  mimochrome IV 8Glu:      12  mg of product pure  (10%) 
                             mimochrome IV 8Lys:      18 mg of product pure (72%) 
 
 
M.W.a 
(g/mol) 
mol number 
(mol) 
Iron (II) 
Acetate (mol)  
Volume 
(L) 
mimochrome IV 3209 1.8 x 10-5 1.8 x10-4 9.0 x 10-2 
mimochrome IV 8Glu 3409 5.8 x 10-6 5.8 x 10-5   3.4 x 10-2 
mimochrome IV 8Lys 4313 7.0 x 10-6 7.0 x 10-5 3.5 x 10-2 
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Figure 8.3 : Schematic representation of insertion of iron in mimochrome; (R), represents mimochrome   
peptide  
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8.7 Analytical methods 
 
Total metal-reconstituted mimochrome IV concentrations were determined on the basis of 
the metal content, derived from flame atomic absorption spectrometry. Standard 
procedures, on a Varian Spectra AA 220 atomic absorption spectrometer, equipped with a 
MK7 burner, were used122. Solutions containing approximately 350 mgL-1 of    Fe(III) 
mimochrome IV 8Glu and Fe(III) mimochrome IV 8Lys in ultra pure metal-free water were 
directly aspired into an air-acetylene flame with no prior treatment. Concentrations were 
obtained both by comparison with calibration curve and by standard addition. No 
differences, which overcome experimental uncertainty, were observed. Fe(III) 
mimochrome IV 8Glu and Fe(III) mimochrome IV 8Lys stock solutions, analyzed for metal 
contents, were appropriately diluted and used for determining the extinction coefficients at 
the Soret band maximum wavelength. 
 
 
8.8 UV/Vis spectroscopy: 
 
UV/Vis spectroscopy: UV/Vis spectra were recorded on a Cary Varian 5000 UV 
Spectrophotometer with 1 cm path length cells. Wavelength scans were performed at 25˚C 
from 200 to 700 nm, with a 300 nm min-1 scan speed. Fe(III) mimochrome IV 8Glu and 
Fe(III) mimochrome IV 8Lys extinction coefficients at the Soret band maximum 
wavelength were determined in phosphate buffered solutions (pH 7; final phosphate 
concentration 1.0 x 10-2M), using a concentrations range from 1.0 x 10-6 M to 1.0 x 10-5 M. 
Fe(III) mimochrome IV 8Glu and Fe(III) mimochrome IV 8Lys pH titration were 
performed in aqueous solution, using HCl solution (0,37% and 3,7%) to lower pH. The 
concentrations of Fe(III) mimochrome IV 8Glu and of Fe(III) mimochrome IV 8Lys were 
3.76 x 10-6 M and 7.00 x 10-6  M, respectively.               
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8.9 Circular dichroism spectroscopy 
 
CD spectra were obtained at 25˚C on a Jasco J-715 dichrograph. Data were collected at 0.2 
nm intervals with a 5 nm min-1 scan speed, a 2 nm bandwidth and a 16 s response, from 260 
to 190 nm in the far-UV region. The spectra in the Soret region were collected at 0.2 nm 
intervals with a 10 nm min-1 scan speed, a 2 nm bandwidth and a 16 s response, collected 
from 470 to 360 nm. Cuvette path length of 1 cm was used for all spectral regions. Sample 
solutions at different TFE/aqueous phosphate ratio (from 0 to 50% TFE) were prepared for 
both Fe(III) mimochrome IV 8Glu (4.02 x 10-6M) and Fe(III) mimochrome IV 8Lys (3.36 x 
10-6 M). CD intensities in the far UV region are expressed as mean residue ellipticities (deg 
cm2dmol-1res-1); intensities in the Soret region are reported as total molar ellipticities (deg 
cm2 dmol-1). 
 
 
8.10 Square wave voltammetry 
 
Square wave voltammetry experiments were carried out under argon with a 
Potentiostat/Galvanostat PAR mod. 273A, using a cell designed for small volume samples 
(Vmin=0.8 ml). Scan rate, 0.01 Vs-1 ; frequency, 5 Hz; pulse amplitude, 0.050 V. an edge-
cleaved pyrolitic graphite (PGE) disc were used as working electrodes for the. A Pt sheet 
and a saturated calomel electrode (SCE) acted as counter and reference electrode, 
respectively. The electric contact between the SCE and the working solution was obtained 
with a Vycor set. Potentials were calibrated against the MV+2/ MV+ couple (MV = 
methylviologen). The cleaning procedure of PGE electrode consisted in a treatment with 
anhydrous ethanol for 5 min, followed by polishing with an alumina (BDH, particle size of 
about 0.015 µm) water slurry on cotton wool for 3 min and a final immersion in an 
ultrasonic pool for about 5 min. All measurements were made in 0.01 M phosphate buffer 
pH 7 and NaClO4 0.1 M, at 25˚C. All mimochromes were freshly prepared before use. 
Equilibrium reduction potentials (E˚΄) were calculated from the peak potential Ep of the 
square-wave voltammograms using the Parry–Osteryoung equation123. 
All reduction potentials reported in this paper are referred to the standard hydrogen 
electrode (SHE). For each species, the experiments were performed at least two times.  
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 A1: Fe mimochrome IV 8Glu UV-vis titration: Fitting equation  
 
Figure A1 shows the pH-dependent coordination equilibria in Fe(III) mimochromes. At 
acid pH (≈ 2) the molecules are characterized from two protonated histidines. Fe(III) 
mimochrome is convert to a species in which both ligands are coordinated to Fe by 
increasing of the pH. The same equilibria could involve Fe-mimochrome IV 8Glu and Fe-
mimochrome IV 8 Glu in pH range 2-8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                
 
Figure A1: Coordination equilibria Fe-porphyrin Histidine as function of pH  
 
We have prove to fit the titration curve of Fe-mimochromeIV 8Glu on the basis of Fe-
histidine  coordination equilibria shown above. 
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+ 
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Ct = [A] + [B] +[C]; 
A= [A]εA +[B]εB +[C]εC   
The total concentration of iron porphyrin is given by eq. E3 and the absorbance is given by 
eq. E4, where εx is the molar extinction  coefficient of each species: 
                                                                             
            
 
The total concentration can be also write how depicted in the equation T1 
           
 
             (XA +XB +XC)= 1                                                                                         
 
 
Therefore inserting equation T1, into absorbance equation (E4) and into equation of the first 
and second acids constant (E1 and E2), we have: 
                                                    
 
 
 
 
              Ka1=                       =                          
            
  
              Ka2=                       =                           
 
 
From equation T4 and T5 can be determinate XA and XC; 
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              XC = 
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The equations T4 and T5 replace XA and XB into absorbance equation (T3), to give: 
 
 
 
 
 
 
 
The equation T6 and T7  replaced XA and XC  into eq.T2 to calculate XB, how shown by the 
equations  T9 and T10 
 
 
 
 
 
 
 
 
 
In final step equation T10 replace DH into adsorbance equation T8 to obtain: 
 
 
 
 
 
 
 
 
 
This equation was used to fit the curve derivate by UV-vis Fe-mimochrome IV 8Glu pH 
titration 
 
 
 
 
 
 
 
 
 
 
 XB  = 
 
 
[H+]2+ Ka1[H+] + Ka1Ka2 
Ka1[H+] 
A= Ct  XB [H
+] εA 
Ka1 
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  XB Ka2 εC 
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A2:  Fe mimochrome IV 8Lys UV-vis titration: Fitting equation 
 
For Fe-Mimochrome IV 8Lys it seen that only one equilibrium being present. This 
indicates that the two pKa are quite similar, therefore we can consider a single equilibrium: 
 
 
 
 
The total concentration of iron porphyrin is given by eq. E1 and the absorbance is given by 
eq. E2, where εx is the molar extinction  coefficient of each species: 
 
 
 
 
 
 
The total concentration can be also write how depicted in the equation M1 
           
 
 
 
 
Therefore replacing equation M1 into absorbance equation (E2) we have: 
 
 
 
Considering  that 
 
 
 
The Ka equation can be written: 
 
 
 
 
On the basis of equation M1, Ka equation become: 
 
 
 
  
 
Ct = [A] +[C]; 
A= [A]εA +[C]εC;   
Ct= Ct (XA +XC); 
 
 (XA +XC) = 1 
Ka1 ≈ Ka2 ≈ Ka 
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[A] +2[H+]          [C] 
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Which gives eq.M6  
 
 
 
 
Replacing eq M6 into eq  M3 and eq M2  
 
 
  
 
 
 
 
  
 
 
XA can be calculate by equation  M8  for give 
 
 
 
 
 
 
 
In final step equation M9 replace XA into adsorbance equation M7 to obtain the equation 
(M10) that we used to fit the curve derivate by UV-vis Fe-mimochrome IV 8Lys pH 
titration 
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